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Summary of the thesis 
Background 
Evidence suggests that girls worldwide are experiencing a decrease in age at pubertal 
onset, but data from Norwegian girls have not been available. Early pubertal timing is 
associated with adverse health outcomes. Pubertal breast development is currently 
categorized using the Tanner B scale and relies on visual inspection and/or palpation. 
Breast ultrasound appears to be a good alternative to this Tanner B assessment because 
it can separate adipose tissue from breast tissue and facilitates both staging and 
volumetric measurements. 
Objectives 
The objectives were to explore ultrasound as an alternative method to assess breast 
development throughout puberty, to investigate the timing of puberty in Norwegian 
girls and construct pubertal references, and to shed light on the relationship between 
anthropometric indicators of body composition and the timing of puberty.  
Methods 
This thesis is based on data from the Bergen Growth Study 1 (BGS1; 2003–2006, n = 
1485, aged 8–15.5 years) and the Bergen Growth Study 2 (BGS2; 2016 and 2017, n = 
703, aged 6–16 years). Data on menarche were recorded in both studies, while breast 
development was assessed only in the BGS2. Six distinct ultrasound-based breast 
stages were described, and the performance of these were evaluated in terms of 
observer agreement and in relation to the standardized Tanner B scale. Descriptive 
pubertal references were estimated from the BGS2. The associations between indirect 
(body mass index, BMI) and direct (skinfolds and waist circumference (WC)) 
measurements of fat with the timing of menarche were explored based on data from 





The ultrasound staging system performed well in terms of the agreement between one 
and two observers; however, direct measurements of size and volume lacked the 
necessary precision. When comparing ultrasound staging and Tanner B staging, an 
overall good agreement was found. A modest decline in the age at menarche was 
observed during the last decade, although pubertal references suggest that pubertal 
timing in Norway is similar to that of neighbouring countries. After adjustment for age 
and sex, both high and low levels of BMI, WC, subscapular skinfold (SSF) and triceps 
skinfold were all associated with an earlier and later menarche. In a fully adjusted 
analysis of all the measurements together, only a high BMI was related to earlier 
menarche, while a low BMI and a low SSF were associated with later menarche.  
Conclusions 
Ultrasound is a feasible method to determine the breast developmental stage. This 
research has clinical implications for the evaluation of puberty in paediatric and 
adolescent female patients in Norway by providing descriptive references based on a 
healthy sample of girls. The decline in age at menarche was not explained by BMI and 
therefore warrants further investigations in population-based studies. BMI was the 
strongest anthropometric predictor of early and late menarche. 
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1. Introduction   
1.1 Normal pubertal development in females 
1.1.1 Physical changes during puberty  
Puberty is the period of physical transition from being a child to becoming an adult. 
Physical changes that take place during female puberty include breast growth and 
maturation, pubic hair development, maturation of the internal genitalia, occurrence of 
the first menstruation (menarche), a pubertal growth spurt until final height is reached, 
and changes in body composition and fat distribution (1, 2). These pubertal events 
usually occur in a predictable sequence. Accelerated height growth has been 
recognized as an early manifestation of puberty together with the breast development 
and the appearance of pubic hair (1). Height growth during puberty accounts for 
approximately 17% of the final height (3). 
Body composition comprises the proportion and amount of fat mass, muscle 
mass, water and skeletal mass. Lean mass includes all body components except fat 
tissue. During puberty, both the amount and proportion of body fat increase (4, 5), and 
the fat distribution relocates more towards the hips (6). The bone mass increases 
during puberty as a result of an increased size of the bones and also due to an 
increased bone density (7). The pubertal gains in height and the accretion of bone 
tissue in puberty precede the peak bone mineralization (8). 
 Menarche is the first menstrual bleeding. When ovulation is not followed 
by fertilization, the body sheds out the uterine endometrial lining, which is termed 
menstruation. Menarche is a relatively late pubertal marker that usually occurs before 
the secondary sex characteristics have reached full maturation and after peak height 
velocity (1). Although menarche is considered a marker for reaching reproductive 
function, the first menstrual cycles often occur without ovulation. Menstrual cycles are 
often irregular during adolescence and particularly during the first years after 
menarche (9, 10). The timing of menarche is an easy pubertal marker to assess and 
requires only a yes/no answer from children and adolescents of different ages that 
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cover most of the pubertal years (status quo data) or alternatively, older girls and 
women can be asked to report when their first menstruation occurred (recall data). 
Hormonal changes in puberty 
The hypothalamic-pituitary-gonadal (HPG) axis is in control of central pubertal 
development. The HPG axis is activated in the first months of life (11) and is silenced 
during childhood due to the inhibition of gonadotropin-releasing hormone (GnRH) 
secretion. Puberty begins when the HPG-axis is re-activated in late childhood when 
GnRH is released from the hypothalamus with increased frequency and amplitude (2). 
Although the mechanism that initiates puberty is not fully understood, it is likely that 
there is both a suppression of the inhibitors of GnRH secretion along with a 
reinforcement of activators of GnRH (2). The release of GnRH drives the secretion of 
luteinizing hormones and follicle stimulating hormones from the pituitary that 
stimulate ovarian growth and the production of estradiol (E2). E2 also stimulates the 
maturation and growth of the breasts. Breast development is recognized as the first 
physical sign of estrogenic activity and thus a clinical sign of the re-activation of the 
HPG axis (12). E2 also stimulates the changing distribution of adipose tissue and bone 
mineral accretion. In puberty, increasing serum levels of E2 lead to the pubertal 
growth spurt. Estrogens stimulates skeletal growth by increasing growth hormone 
secretion and locally within the growth plate. Higher concentrations of E2 stimulate 
the fusion of the epiphyseal plates and stop linear growth; in other words, oestrogen 
has a biphasic effect on growth (13). 
The activation of the hypothalamic-pituitary-adrenal-axis leads to a rise in 
dehydroepiandrosterone and androstenedione, two adrenal androgens produced in the 
zona reticularis of the adrenal gland. This event is termed adrenarche (2), and it occurs 
independently of gonadal (ovarian) activation (HPG axis) and is hormonally distinct 
from gonadarche (14). Clinical and visual signs of adrenarche are pubic hair growth 
(pubarche), axillary hair growth, acne and adult body odour; these hormones also 
contribute to advancements in skeletal maturation (2). 
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Genetic control of puberty 
The timing of menarche in mothers is associated with the age at menarche in their 
female offspring (15-20), and similar associations have been shown for pubertal 
markers such as pubic hair and breast development (18-20). This indicates that 
pubertal timing is heritable. A large genome-wide association study identified almost 
400 significant single nucleotide polymorphisms (SNPs) that were associated with the 
age at menarche (21). These SNP variants were found to account for 7.4% of the 
variance in age at menarche, which corresponded to ~25% of the estimated heritability 
(21). 
1.2 Assessing breast development 
The assessment of breast development is important when evaluating the timing of 
female puberty in clinical settings. In the 1960s, the British paediatrician James Tanner 
(1920–2010) described the longitudinal development of normal puberty using a system 
based on the development of secondary sex characteristics that is still in use today 
(22). Breast and pubic hair development were classified into one of five consecutive 
stages of maturation: breast stages B1–B5 (Figure 1) and pubic hair stages PH1–PH5, 
respectively (1). Stage 1 is the prepubertal stage, while Stage 2 marks the first 
appearance of the breast bud (including enlargement of the areola) and/or pubic hair. 
Stages 3 and 4 are the subsequent pubertal phases, while Stage 5 indicates the mature 
or adult stage (1). The Tanner scale is almost universally used in clinical and scientific 
settings and is therefore regarded as the standard when alternative assessment methods 
are tested (23-26). The widespread use of the same classification system makes it 
possible to compare data from different studies. The pubertal references currently in 
use in Norway, based on the Tanner staging system for breast and pubic hair 
development, are based on data originating from the Copenhagen Puberty Study 
conducted from 1991 to 1993 (27-29). 
The Harpenden Growth study, from which the Tanner staging system evolved, 
also provided normal age references for breast and pubic hair development, and 
menarche. The inter-individual variation in timing is rather large, and the age limits 
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where normal puberty start are relatively wide (1). The mean age at Tanner B2, 
thelarche, was 11.2 years. The age at onset of pubic hair (Tanner PH2) was 11.7 years, 
and menarche occurred at a mean of 13.5 years (1). To determine a normal age range 
for pubertal onset, lower and upper age limits have been statistically defined as the 
95% prediction interval of the age at onset. Based on this, the breast development 
should start between the age of 8 and 13 years. This lower limit of precocious puberty 
(thelarche before 8 years) is still maintained in the current Norwegian guidelines (29), 




Figure 1 Tanner stages of breast development. (The original photographs 
used in the paper by Marshall and Tanner (1)) 
1: Tanner B1: Prepubertal, elevation of papilla only 2: Tanner B2: Breast bud 
stage; elevation of breast and papilla as a small mound, enlargement of 
areola diameter. 3: Tanner B3: Further enlargement of the breast and 
areola, with no separation of their contours. 4:  Tanner B4: Projection of the 
areola and papilla to form a secondary mound above the level of the breast. 
5: Tanner B5: The mature stage; the projection of the papilla only, due to 
recession of the areola to the general contour of the breast (1).  Reproduced 
from [Variations in pattern of pubertal changes in girls, W. A. Marshall and 
J. M. Tanner, 44, 291–303, Copyright 1969] with permission from the BMJ 
Publishing Group, Ltd. 
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Palpation of the breast bud, a method in which the fingers are used to examine 
the ‘texture’ of the breast, was not conducted in the Harpenden Growth Study. Instead, 
the assessments were based on photographs, which do not allow for palpation by 
definition (1). However, several reviews and researchers have cautioned that bias may 
occur when assessing pubertal development using the Tanner B stages, particularly in 
overweight and obese girls (2, 25, 33-35). Especially worrisome is the 
misclassification of adipose breast tissue (lipomastia) as glandular breast tissue, which 
may result in over-rating of breast maturation. Thus, girls may be considered as 
pubertal when they are not. Both visual inspection and palpation are therefore advised 
when examining breast development according to Tanner B staging to decide if 
thelarche has occurred (2, 23, 25, 33, 35, 36). 
The interobserver agreement, which is the ability of a single or different 
observers to obtain a similar Tanner B stage in the same patient, has shown varying 
results (37-40) and has not always been found reliable (41), meaning that Tanner B 
assessments of pubertal breast maturation can be challenging. The method has also 
been referred to as subjective (35). Therefore, although Tanner staging remains the 
standard method for staging puberty, its reliability is not necessarily promising. 
Ultrasound has been proposed as a method that can better determine breast maturation 
(42), and has the ability to discriminate glandular breast tissue from adipose tissue 
(26). 
1.2.1 Breast ultrasound 
Ultrasound is the use of sound waves above 20 kHz. Ultrasound images show how 
ultrasound waves are reflected by different tissues, and results in different grades of 
brightness. Thus, the normal appearance of the breast as seen on ultrasound varies 
depending on the proportion and composition of glandular, fatty and fibrous tissue 
(43). To date, paediatric breast ultrasound is occasionally performed if breast 
abnormalities, such as pain or a palpable mass, are found on clinical examination. 
Breast pathology in women is often associated with breast cancer. However, such 
pathology is very rare in children and adolescents (44). In most cases where breast 
disease is suspected based on the clinical examination, a breast ultrasound typically 
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reveals a normal appearance or benign findings (45, 46). Ultrasound is the preferred 
initial imaging modality in children because the developing breast is susceptible and 
vulnerable to biopsies and is also sensitive to ionizing radiation from mammography 
(47, 48). 
Breast ultrasound to stage pubertal development 
The breasts undergo changes during infantile growth, puberty, pregnancy, lactation 
and post-menopause (49). In the newborn, the breast is a rudimentary organ that 
consists mainly of a network of extending ducts (45). During childhood, the mammary 
gland development keeps pace with the general growth but does not appear to develop 
any further (49). At pubertal onset, there is an expansive proliferation of ducts, and the 
breast starts to develop by growing breast buds. The subcutaneous adipose and 
connective tissues increase in volume, and the ducts elongate and extend into the 
adipose tissue. The adult breast tissue mainly consists of two components: 
fibroglandular tissue and fat (50). 
An ultrasound examination of a pubertal breast shows the skin, nipple, fat, 
Cooper’s ligaments, ducts, breast parenchyma, pectoralis muscle, pleura and ribs. The 
skin and Cooper’s ligaments appear hyperechoic (lightly shaded grey), while the 
mammilla is hypoechoic (dark grey to black) (51). Fatty tissue appears hypoechoic 
(43). The echogenicity of fibrous tissue can appear intermediate on ultrasound (43). 
The fibres called Cooper’s ligaments can be characterized as the framework holding 
the glandular and fatty tissues together (51). The glandular tissue appears hypoechoic 
until the mature phase, when the ducts and lobules spread into the increasingly fatty 
breast and then take on a more heterogeneous appearance (43) (for illustrations, see 
Figure 2 of this thesis and Figure 1-6 in Paper I). 
Because of certain identifiable morphological hallmarks that occur during 
puberty, an interpretation of the changing appearance of breast tissue facilitates a 
classification of breast development using ultrasound. These appearances were first 
observed and characterized by Bruni et al. in a study of 48 healthy girls from 8–14 
years of age that represented Tanner B1 to B4 stages (26). They compared breast 
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ultrasound findings with the Tanner B stages, breast circumference and oestrogen 
levels and found that ultrasound grading of the pubertal breast into one of five levels 
(A–E) was closely related to increasing oestrogen levels (26). Similar descriptions of 
five ultrasound stages that occur during puberty were reported by Garcia et al. in 2000 
(52) and indicated a close correlation to the Tanner B stages with their names of 
Tanner Stage 1, Tanner Stage 2, etc. The differences between these ultrasound 
descriptions were primarily regarding the first stages; Stage A was described as the 
absence of a glandular bud corresponding to both the complete absence of clinically 
evident mammary growth and adiposity in the breast region (26), while Tanner Stage 1 
was defined as prepubertal with an ultrasound that shows ill-defined, hyperechoic, 
retro-areolar tissue in most cases (52). However, while the descriptions from Bruni et 
al. relied on shape and size, Garcia et al. included a more detailed description of the 
ultrasound images’ appearance (descriptions are given in Table 1 of Paper I) (26, 52). 
Ultrasound staging is used in clinical studies to determine the extent of breast 
maturation (42, 53-56), and rising gonadotropin and E2 levels have been shown to be 
correlated with the maturation of breast tissue as observed using ultrasound 
(morphological stage) (26, 42, 53, 55). There is some variation between the Tanner B 
staging system and ultrasound-based systems. For example, the Tanner B2 stage does 
not necessarily equal Stage B or Tanner Stage 2 (26, 42, 53, 55). However, these 
studies are small (48–80 participants) and vary regarding their recruitment and 
inclusion criteria as follows: the inclusion of girls that are expected to have already 
entered puberty (42, 55), obese girls only (55), girls with a limited age range, or 
inclusion based on probable pathology (e.g. central precocious puberty) (42, 54). Thus, 
there seems to be a lack of data on how breast ultrasound compares to Tanner B 
staging in a larger study population of healthy girls of different ages and 
developmental stages.  
Direct measurements of glandular breast tissue 
Ultrasound has also been used to measure the size of glandular tissue as either the 
diameter (54) or both the diameter and the depth to facilitate a volumetric estimate 
using an ellipsoid formula (V = D1 x D2 x D3 x 0.523) (42). Breast size is associated 
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with increasing ultrasound stages (54). None of the studies using ultrasound for 
staging the breast maturation and/or measurements of glandular tissue have made a 
systematic report of the reliability or repeatability of such assessments, and the 
observer agreement of the staging systems has not been tested. 
In summary, ultrasound allows for phenotyping a hormone-sensitive and 
developing organ by characterizing its appearance and size without radiation and 
appears to be a promising alternative to Tanner B examinations of breast development. 
Accurate interpretation of the ultrasound images depends on in-depth knowledge of 
breast anatomy as well as on normative data and reference estimates based on healthy, 
normal-weight girls across all pubertal stages. However, the intra- and inter-observer 
agreement and agreement with the standard method (Tanner B) is currently unknown. 
The presence of slightly different definitions also limits the comparability of findings 
between studies.   
1.3 Secular trends in the timing of puberty 
1.3.1 Historical trends in the timing of menarche 
The age at menarche declined between the 19th century and the first half of the 20th 
century in Western countries (57-60). In Norway, the menarcheal age fell from above 
15.6 years for women born around 1850 to about 13.3 years for women born after 
1940 (58) and has been stable at around 13 years since then (61-66). This finding is 
consistent with trends in other European countries (27, 30, 31, 67). The rapid decline 
in the age at menarche from the 19th to the 20th century has been attributed to 
improved living conditions and health, a better nutritional status and improved hygiene 
(59, 60). 
1.3.2 Recent trends in pubertal timing  
Two large recent cross-sectional studies from the United States have received 
particular attention in light of renewed secular changes towards earlier maturation in 
girls: The Pediatric Research in Office Settings (PROS) (40) and the Third National 
Health and Nutrition Examination Survey (NHANES III) (68, 69). The PROS study 
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included 17,077 girls aged 3–12 years who were seen in paediatric practices from 
1992–1993. The NHANES III was a nationally representative study that included girls 
aged 8–17 years and took place from 1988–1994. The PROS study reported that 
participants reached the Tanner B2 stage at an average age of 10.0 years in white 
American girls and 8.9 years in African-American girls, and that girls demonstrated 
breast development at younger ages (0.6–1.2 years earlier) than previously reported 
(40). The age at onset of both breast and pubic hair development was lowest in the 
PROS study, but both the PROS and NHANES III reported an earlier onset when 
compared to previous studies. The American studies also emphasized racial 
differences in the timing of female puberty, with black girls maturing at younger ages 
than white girls (40, 68, 69). There was also a steeper decline in the age at pubertal 
timing among black girls (40, 70). Both of these studies have been the starting point 
for methodological discussions regarding puberty studies (35), with an emphasis on 
the ages of participants, definitions of when puberty is precocious (32), Tanner B 
assessments (with or without breast bud palpation) and also the relationship between 
anthropometry and puberty timing (71). A further decline in age at onset of breast 
development has been shown in a more recent study from the United States (34). 
European studies from Denmark, Belgium and the Netherlands conducted 
around the same time as the PROS study (27, 30, 31) could not document the same 
trends in pubertal onset. However, a study published in 2009 showed a decline in the 
mean age at pubertal onset during a 15-year-period from 10.9 years in 1991–1993 to 
9.8 years in 2006–2008 in Denmark (72). The mean age of menarche did not decrease 
to the same extent (0.3 years). A decrease in the age at pubertal onset has also been 
suggested in Greece (73) and in a British study based on self-reported data (15). 
Studies reporting ages at thelarche were recently reviewed by Eckert-Lind and 
colleagues (74). They concluded that there has been a worldwide decline in age at 
pubertal onset based on studies published from 1977–2013. Subsequently, the trends in 
pubertal timing seem somewhat ‘asymmetrical’, with earlier breast development and a 
stabilization of age at menarche during the same period. It has been discussed if the the 
observed decline in age at thelarche and not in age at menarche is attributable to the 
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challenges of assessing breast development reliably, with interpretations of fat tissue 
as glandular breast tissue (35). 
1.4 Health outcomes associated with early pubertal onset 
The early timing of menarche is associated with adverse health outcomes in adulthood 
(75). Increased risk of cardiovascular disease, type 2 diabetes (76), all-cause mortality 
(77, 78), increased risk of adult obesity (79-81), and different types of cancers (75), 
especially breast cancer (82, 83), have all been associated with early menarche.  
Earlier pubertal timing is also related with psychosocial problems in girls, such 
as depression (84), mental disorders, lower self-esteem, a non-favourable body image 
(85) and higher rates of substance use and abuse (86). Earlier menarche has been 
related to an increased risk of depressive symptoms and antisocial behaviour in early-
middle adulthood, and is suggestive of that the elevated risk of poorer mental health 
during adolescence may not attenuate in adulthood (87). 
1.5 Factors that influence pubertal timing  
1.5.1 Perinatal factors 
In girls, rapid weight gain in infancy has been associated with a higher risk of earlier 
pubertal development (88-92), and so has a small birth size (91, 92) and a high birth 
weight (90). Other perinatal factors that have been linked to pubertal timing are 
maternal smoking during pregnancy (19, 93) and maternal pre-pregnancy body mass 
index (BMI) (94). Findings from a recent review on pubertal timing after preterm birth 
suggested that the existing evidence was not supportive of an earlier (or later) onset of 
puberty among premature girls (95). 
1.5.2 Endocrine-disrupting chemicals  
Endocrine-disrupting chemicals (EDCs) are single or mixtures of chemicals that 
interfere with or alter hormonal action by exhibiting endocrine properties, i.e. 
estrogenic, antiandrogenic or thyroid actions (96). There are many different groups of 
EDCs and although the majority of them are man-made, some are naturally occurring. 
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It has been suggested that pubertal timing and distribution are affected by exposure to 
EDCs (97-99). Because the presence of and exposure to man-made EDCs are 
widespread (100), they have been implicated as a possible contributor to the trend of 
earlier pubertal onset (40, 72, 100). 
1.5.3 Stress and socioeconomic factors  
Stressful conditions during childhood and adolescence have also been associated with 
pubertal timing, particularly a younger age at menarche. Stressful events may include 
family conflicts, divorce, and the absence of a parent (101, 102) or adoption (33, 103). 
The very poor socioeconomic conditions that typically occur during wartime have 
been related to a later occurring menarche (104). The effect of socioeconomic status 
on pubertal timing has shown varying results in Western countries (34, 105). 
1.5.4 Body mass index, body composition and the timing of 
puberty 
Studies have found that girls who mature early have higher BMI or BMI standard 
deviation scores (SDS) than their less mature peers (71, 105-108). Similarly, several 
studies have observed that girls with an early menarche have a higher BMI than girls 
with an average or late timing of menarche (31, 109, 110). The association between 
BMI and early pubertal timing has therefore been related to the epidemic of paediatric 
overweight and obesity (34, 40, 111-115). High prevalence of overweight and obesity 
in children is a worldwide phenomenon (116) that is also found in Norway, where the 
prevalence has increased from the 1970s to the 2000s (117).  
Decline in ages at menarche have been attributed to the increased prevalence of 
overweight and obesity or differences in BMI when similar cohorts investigated at 
different time points have been compared (72, 109, 118). Nevertheless, causality is not 
established by these studies due to their cross-sectional design. Longitudinal studies 
have also found associations between a higher weight status in childhood before 
pubertal onset (down to three years in one study), and younger ages at pubertal timing 
(15, 34, 90, 119-123). These studies suggest that increased body weight, including the 
presence of overweight and obesity, may lead to the early onset of puberty. 
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However, there are some inconsistencies in these findings, and not all studies 
point towards overweight and obesity as the only reason for the trend towards an 
earlier timing of puberty. A Danish longitudinal study observed that the trend towards 
earlier age at puberty between 1930 and 1969 occurred irrespective of the children’s 
prepubertal BMI. Thus, obesity could not be the only responsible factor for the decline 
(123). Other studies have found that the age at menarche has remained stable despite 
an increasing prevalence in overweight and obesity (17, 30, 67) and that the decline in 
age at menarche remains significant when controlling for the BMI SDS between 
studies (105). 
In 1970, Frisch and Revelle published the critical weight hypothesis, which 
suggested that a body weight of approximately 48 kg (124) and then later also body fat 
(125) were required for the occurrence of menarche. Their hypothesis received 
criticism, as several studies could not replicate their findings (79, 126-128). However, 
this publication did lead several studies to focus on the impact of body composition on 
puberty and also the possible mechanisms behind this relationship. Leptin, an appetite-
regulating hormone, has been identified as one potential link between nutrition and 
reproductive function because it acts on the hypothalamus as a signal of energy status 
to the reproductive system by modulating the Kiss1/Kiss1R system (129). In cases 
with a negative energy balance, the hypothalamic Kiss1 system may contribute to the 
suppression of reproductive function (129). Leptin is secreted by fat tissue, and leptin 
levels are correlated with the amount of fat that is present (e.g. BMI and circulating 
leptin levels) (130). A threshold level of leptin appears to be a permissive factor for 
puberty to begin, but although leptin stimulates puberty, it cannot initiate the pubertal 
onset alone (131). The interrelationship between overweight and obesity and the 
timing of puberty is still not fully understood (12, 132). 
1.5.5 Weight-related anthropometric measures 
BMI, which is calculated as kg/m2, is the most frequently used measure of weight 
status in clinical settings and population studies. In adults, a BMI > 25 kg/m2 
corresponds to overweight, while > 30 kg/m2 is defined as obesity. Standard 
international definitions for underweight, normal weight, overweight and obesity, as 
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well as for underweight in children and adolescents, have been developed by the 
International Obesity Task Force (IOTF) (133-135). Consistency with adult cut-offs 
for overweight and obesity was estimated by extrapolating the cut-offs for a BMI of 25 
and 30, at age 18 to children and adolescents using centile BMI curves, and with 
similar exercice done for the definitions of underweight (134). Calculation of the SDS 
for BMI and other anthropometric measurements (e.g. waist circumference (WC) and 
skinfolds) is carried out using growth references. The SDS refer to the position of a 
child on the reference chart (e.g. the number of SDs above or below the median), while 
the SD refers to the standard deviation of the distribution. 
BMI is a weight-for-height measure and does not offer information about body 
composition or fat distribution. However, BMI in the overweight or obesity range in 
children is usually explained by excess fat tissue. The amount of fat is known to vary 
between children with similar BMIs (136-138). Although BMI has a high specificity 
for diagnosing high amounts of body fat after being adjusted for age and sex, its 
sensitivity is lower. Thus, BMI has the ability to detect children who are (clearly) 
overweight and obese, but this measure may be less accurate at identifying those with 
a high amount of fat mass and a BMI within the normal range (139). 
Skinfold thicknesses in children are commonly assessed at the subscapular 
(SSF) and/or triceps (TSF) skinfolds. Skinfold measurements are direct measures of 
subcutaneous fat and have been shown to correlate better with measurements of total 
body fat percentage than BMI or WC (5). In Norway, the increase in skinfold 
thickness exceeded the increase in weight-for-height from the 1970s to 2003 (117). 
Compared to BMI, skinfolds are interesting because they demonstrate the amount of 
subcutaneous fat, while the BMI represents changes or amounts of other tissues as well 
(140). Up-to-date Norwegian references for SSF and TSF currently exist (141).  
WC reflects the amount of abdominal fat. Central adiposity has been shown to 
identify both a high (5, 142) and a low trunk fat mass in children and adolescents (142) 
and also has been found to explain the largest part of variance in BMI followed by the 
waist-to-height ratio and skinfold assessments (140). Increased abdominal fat (WC) in 
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childhood has been associated with an earlier pubertal timing (120). Norwegian 
references for WCs are available (143).  
Within normal weight and moderately overweight children, defined by BMI, 
there are large variations in weight-related anthropometric measurements, and 
anthropometric measurements beyond BMI may have a potential to add information 
about fat accumulation in children that are not obese (140). A link between earlier 
pubertal timing and overweight and obesity is well documented, but few studies have 
investigated how this association could depend on body composition, more 
specifically body fat mass, rather than indices of total body weight like the BMI, 
which may be a method to explore the relation between adiposity and pubertal timing. 
Weight-related anthropometric measures beyond BMI might add valuable information 
into the literature on the association between body composition/weight status and 
timing of pubertal development. 
 
 
Literature review completed June 2020.  
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2. Aims and objectives 
The overall aims of this thesis were to develop a framework for ultrasound 
assessments of pubertal breast development by providing descriptive data on the use of 
ultrasound to assess breast development, to estimate the timing of puberty with this 
new method, to provide data on the current timing of puberty in healthy Norwegian 
girls and adolescents and to study how anthropometric measurements are associated 
with pubertal timing. 
The specific aims of the papers included in this thesis are as follows: 
I  To provide a description of the ultrasound staging of pubertal breast 
development, to assess the intra- and inter-observer agreement of breast 
maturity staging with ultrasound, and to estimate the precision of direct 
measurements of the depth and diameter of glandular tissue in healthy 
peripubertal girls. 
Hypothesis: Ultrasound is a reliable method that can be used to assess the 
breast developmental stage and size of the mammary gland, with acceptable 
intra- and inter-observer agreement.  
II  To estimate the current timing of pubertal development and descriptive 
reference ranges for ultrasound-based stages of breast development, 
Tanner B and PH stages, and menarche, to compare the ultrasound and 
Tanner methods of staging pubertal breast development, and to assess 
recent changes in age at menarche. 
Hypothesis: Ultrasound stages require their own reference ranges because they 
are based on different characteristics. Girls are more often assessed as pubertal 
by the Tanner B method than by the ultrasound method due to the interpretation 
of adipose tissue as pubertal breast tissue. The age at menarche is similar as 
previously reported.   
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III To compare the association between menarche and an overall index of 
body weight (BMI) with the association between menarche and more 
direct measures of fat mass (skinfolds and WC).  
Hypothesis: Central and subcutaneous fat have stronger impact on pubertal 




3. Methods  
3.1 Bergen Growth Studies: Setting and design 
This thesis is based on data from the first and second Bergen Growth Studies (BGS1 
and BGS 2), which were both cross-sectional studies. As this thesis is solely focused 
on the pubertal development in girls, data on boys, which were also included in both 
studies, are not discussed here. 
3.1.1 The Bergen Growth Study 1 
The BGS1 aimed to identify and describe normal patterns of growth and development. 
Data were collected from more than 8000 children from 0–19 years of age recruited 
from health clinics, kindergartens and public schools from November 2003 to 
December 2006. The study was population-based, and the current national growth 
references are based on data from the BGS1 (141, 143, 144). Other than recording 
menarche in girls, the issue of puberty was not investigated in the BGS1. 
3.1.2 The Bergen Growth Study 2 
The main aim of the BGS2 was to describe normal pubertal development in 
Norwegian girls. The study was conducted from January to June in 2016 and also in 
February 2017. The participants were recruited from a random selection of public 
schools stratified by their town area in the municipality of Bergen, Norway. All girls in 
the selected schools were invited to participate. The children were investigated during 
school hours. All participants, regardless of their ethnic origin, were included in the 
analyses unless otherwise stated in the results. A short summary of the study 
populations and characteristics in BGS1 and BGS2 is shown in Table 1. 
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Table 1 Short summary of the study populations used in this study from the 
Bergen Growth Studies 1 and 2.   
 
Abbreviations: BMI: Body mass index, IOTF: International Obesity Task Force, US 
B: Ultrasound-based breast stage: Tanner B: Tanner breast stage, Tanner PH: Tanner 
pubic hair stage. *Blood samples were collected in 2016, and are only briefly discussed in 
this thesis. Modified from Supplementary Table 1 in Paper II, with permission. 
 
Study characteristics Bergen Growth Study 1  Bergen Growth Study 2 
Year of study 2003–2006 
 
2016 + 2017 (test-retest study) 
Study setting 19 randomly selected schools 
(all pupils invited) 
 
7 randomly selected schools 
(all pupils invited) 
N 1481  703  
Age, mean (SD) 11.8 (2.2)  11.1 (2.8) 
BMI, mean (SD)  18.5 (2.9)  18.3 (3.2) 
BMI z-score, mean (SD) -0.01 (1.0)  0.04 (1.0) 
Exclusion Chronic illness (n=39) 
 
Chronic illness (n=27) 
Pubertal markers Menarche (status quo and 
recall) 
 US B 
Tanner B 
Tanner PH 
Menarche (status quo and 
recall) 
Blood samples * 
Participation rate 69% in primary school (6–12 
years) 
53% in middle school (13–14 
years) 
 52.1% in primary school (6-12 
years) 
43.3% in middle school (13-16 
years) 
Ethnic composition (%) Norwegian/Nordic: 1294 
(87.1%) 
European: 67 (4.2%) 
Non-European: 120 (8.1%) 
 
Girls with a known origin: 466 
Norwegian/Nordic origin: 381 
(81.2 %) 
European origin: 27 (5.8 %) 
Non-European: 51 (11.1%) 
Parental education 
(highest degree) 
   
  No secondary  
education 
71 (7.6%)  16 (3.3%) 
  Secondary education 280 (29.9%)  82 (17.1%) 
  Higher education  583 (62.4%)  382 (79.6%) 
Weight status (IOTF)    
  Underweight 144 (9.7%)  47 (7.2%) 
  Normal 1128 (75.9%)  504 (78.1%) 
  Overweight 180 (12.1%)  80 (12.4%) 
  Obese 33 (2.2%)  14 (2.2%) 
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3.2 Participants 
Paper I is based on data from a test-retest study that was conducted in February 2017 
as part of the BGS2. It is a methodological paper that investigated the agreement both 
within and between observers when using ultrasound to assess breast development in 
puberty. For this study, a random sample of 116 girls aged 6–16 years were invited to 
participate; a total of 76 (65.5%) agreed, and 57 girls aged 6.1–15.9 years made up the 
final sample. Due to time constraints, not all girls who agreed could be included. 
The descriptive references for pubertal development in Paper II are based on 
data collected between Januarty and June 2016 (n=667) and the 57 girls that 
participated in the test-retest study in February 2017. The seven schools were situated 
in mostly urban environments in the Bergen municipality. All girls (n=1349) attending 
the selected schools were invited to participate. Parental consent was obtained for 667 
girls in the BGS2 in 2016 (participation rate: 49.4%). Children with any known 
chronic illnesses that were likely to affect their growth were excluded (e.g. coeliac 
disease, diabetes, heart disease, epilepsy, hypothyroidism, anorexia, cancer or a kidney 
disorder), which led to the exclusion of 27 girls from the BGS2. 
Paper III is based on data from girls who participated in the BGS1. This study 
included a total of 4035 girls from 0-19 years of age. Data on menarche was available 
from 1481 girls who were between 8 and 15.5 years of age. A total of 39 girls within 
the target age group were excluded due to chronic illness following the same criteria as 
above. 
3.3 Ultrasound technique and assessments  
The ultrasound-based scoring system used to characterize the maturation of glandular 
breast tissue (US B) in Papers I and II was primarily based on a description published 
by Garcia et al. (52) but was adapted to reflect relevant details and characteristic 
features given by Bruni et al. (26) (further details are given in Table 1 of Paper I). For 
the purpose of observer training and quality control, the ultrasound method was piloted 
in healthy girls, and rater agreement was sought regarding standard views and 
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measurement points. Moreover, all ultrasound examinations that took place during the 
first three days of data collection in the BGS2 were done jointly by the study nurse 
(Ingvild Særvold Bruserud, ISB) and an experienced pediatric radiologist (Karen 
Rosendahl, KR). These training and calibration sessions were used to standardize the 
ultrasound procedure and lead to an adjustment in the ultrasound protocol by adding a 
distinct second prepubertal stage: US B0 (Figure 2).  
3.3.1 Ultrasound procedure  
All ultrasound examinations were performed with the girl in the supine position and 
her arms along her sides. The left breast was examined in all participants. For the 
purpose of the test-retest study, we included one breast only to avoid issues with 
dependent data. In the BGS2, the left breast was examined in all girls, and when the 
right breast appeared more mature, the right breast also. This was the case in three 
girls. The left breast was chosen over the right because examining the left breast 
allowed the observer’s (right) arm to rest stable and calm, with the observer sitting on 
the girls’ right side during all examinations. 
The ultrasound device used for examination was a SonoSite Edge (Fujifilm 
SonoSite, USA) machine with a 15-6 MHz (5-cm) linear transducer. The probe was 
placed at 90º to the skin and centred on the nipple to produce a sagittal standard 
section that was used for all measurements and staging procedures. Based on this 
standard section, the depth and diameter of the breast were measured, followed by 
morphological staging on a scale from US B0 to US B5 (Figure 2).  
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Figure 2 Ultrasound-based stages of pubertal breast development (US B) 
A A midsagittal view through the left breast in a 7.1-year-old girl conforming 
to stage US B0. The image shows a small elongated mass (asterisk) that is 
hypoechoic relative to the surrounding subcutaneous (SC) adipose tissue. 
The ribs (R) are located posterior to the pectoral muscle (P) (145). 
B A midsagittal view through the left breast in a 10.8-year-old girl that 
corresponded to stage US B1. The breast tissue is hyperechoic compared to 
the surrounding subcutaneous tissue (SC), but not to the pectoral muscle (P) 
and has a triangular shape (asterisk) (145). 
C A midsagittal view through the left breast in a 9.7-year-old girl conforming 
to stage US B2. The image shows well-defined breast tissue that appears 
hyperechoic in relation to the subcutaneous (SC) tissue, but not to the 
pectoral muscle (P), and has a small hypoechoic roundish center (asterisk). 
Rib (R) (145). 
D A midsagittal view through the left breast in a 10.7-year-old girl that 
indicated stage stage US B3. The breast tissue appears hyperechoic with a 
hypoechoic ‘spider-shaped’ center (asterisk). Pectoral muscle (P) (145). 
E  A midsagittal view through the left breast in a 12.0 –old-girl conforming to 
stage US B4. The image shows hypoechoic glandular tissue in the 
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subareolar area that has a rounder shape compared to the US B3 stage. 
The ribs (R) are located posterior to the pectoral muscle (P) (145). 
F A midsagittal view through the left breast in a 13.9-old-girl conforming to 
stage US B5. Mature breast tissue is seen as a heterogeneous mass without 
any hypoechoic center. Pectoral muscle (P) (145).The figure and figure text 
are only slightly modified from the Supplemental Figure 1 in Paper II. 
Reprinted with permission. 
 
The longest diameter of the fibroglandular area was measured. In this study we 
used a 5-cm long linear transducer. For breast diameters larger than 5 cm but less than 
10 cm, we combined the measurements from two scans in the same plane (Figure 3). 
The depth was measured from the nipple and then vertically down towards the pectoral 
muscle and/or the end of the glandular tissue. The degree of compression was held to a 
minimum, as discussed during the training and standardization sessions. Direct 
measurements of the depth and diameter were chosen for the purpose of calculating 
the glandular volumes using the formula for a conical shape (formula: volume = (π/3) 
* radius2 * depth), as described elsewhere (25, 42). 
  
Figure 3 Mid-sagittal view through the breast in an 11-year-old girl with 
ultrasound stage 3 shows well-defined tissue which appears hyperechoic in 
relation to the subcutaneous tissue (SC) with a hypoechoic “spider/octopus-
shaped” center (asterisk). The hypoechoic “arms” extend into the glandular 
hyperechoic tissue (arrows). Two consecutive measurements of the 
diameter are shown. The upper part of the glandular tissue (left image) is 3.1 
cm, and the lower part of glandular tissue (image to the right) is 4.1 cm. The 
ultrasound image of the same breast showed a depth of 1.6 cm measured 
from the interface between glandular tissue and the pectoral muscle to the 
mammilla (not shown).  Figure is identical with Figure 4 a in Paper I. 
Reprinted with permission 
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A preliminary US B stage was recorded during the examinations of 166 girls in 
the BGS2, but the standardized ultrasound images were stored to allow a final decision 
on the stage at a later time. This procedure was carried out because a final decision 
could not be reached within a certain time, and we wanted to avoid prolonged 
exposure of the girls. To examine the agreement between live scoring and scoring by 
using the ultrasound images only, a total of 122 ultrasound images (> 10 from each age 
year) were re-scored after a period of two years by ISB, who was blinded to the 
previous results,. The agreement between the original and rescored stage had a 
Cohen’s kappa with linear weights of 0.76 (95% confidence interval [CI]: 0.698–
0.812), which is considered good. 
3.3.2 Reliability of the ultrasound examination of the breast 
To assess the intra- and inter-observer agreement of the ultrasound measurements of 
glandular depth and diameter and staging, two observers (ISB and KR) independently 
performed ultrasound examinations of the breast in 57 girls (Paper I). Each 
examination included the determination of the development stage and direct 
measurements of the glandular tissue. The first examination by the main observer was 
compared to her second examination performed after an interval of at least 20–35 
minutes (intra-observer) and also to the examination carried out by an expert (second) 
observer (inter-observer).  
3.4 Tanner assessments of breast and pubic hair 
development 
The breast stages according to Tanner were assessed by visual inspection and 
palpation (1), as illustrated in Figure 1 of this thesis. The Tanner B stage was 
determined before the ultrasound assessment, with the girl in the supine position. 
Pubic hair development was also assessed according to the method described by 
Tanner and Marshall (1). The Tanner PH stage was not included in the initial protocol 
but was systematically recorded from February 22nd until the end of the data 
collection in BGS2 in 2016. Out of the 453 girls who were asked for the assessment of 
pubic hair, 372 (82%) consented and had their Tanner PH stage assessed. The original 
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photographs published by Marshall and Tanner (1) and the modified illustrations 
published by Rasmussen et al. (38) were used as guide for the assessment of both 
Tanner B and PH stage. 
3.5 Menarche  
All girls in the BGS2 were asked if they had experienced menarche, except for those 
who participated in the test-retest study. In the BGS1, all girls from the 1st to 10th 
grade of primary school (ranging from 6 to 15–16 years of age) with clinical signs of 
breast development were asked if they had experienced menarche. Girls younger than 
8 years (in the BGS1) were not included in the analysis because none of them had 
reached menarche. Signs of breast development were not recorded. Girls older than 
15.5 years of age from the BGS1 were also excluded from the analysis of menarche 
because menarcheal status was not systematically recorded above this age. In both 
studies (BGS1 and BGS2), girls who had experienced menarche were also asked if 
they could recall the age or date (year and month) of menarche. 
3.6 Anthropometric measurements 
All examinations of the girls in the BGS2 were conducted by the same female nurse 
(ISB), while children in the BGS1 were examined by a total of 13 study nurses and 
one paediatrician (Pétur B. Júlíusson). All observers were trained ahead of the data 
collection and used standardized techniques (146). Height was measured with the girls 
standing against a Harpenden Portable Stadiometer (Holtain Ltd., Crosswell, UK) and 
recorded to the nearest 0.1 cm. Weight was assessed using an electronic scale while 
the participants wore light clothing (Tanita MC-780MA, Tanita Corp. of America, 
Inc., Illinois, USA) in the BGS2 and with a Seca personal digital scale (Hamburg, 
Germany) in the BGS1. Both scales had a precision of 0.1 kg. 
A Holtain Tanner/Whitehouse Skinfold Caliper (Cosswell, UK) was used for the 
skinfold measurements. Skinfolds were assessed on the participants’ left sides. The 
SSF was measured by picking up a skinfold inferomedially with the thumb and 
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forefinger and setting the caliper about 2 cm below the inferior angle of the left 
scapula. The skinfold measure was read 1–3 seconds after releasing the skin from the 
caliper. The TSF was measured between the acromion and the caput radii of the 
posterior overarm with the arm hanging straight down. Further details are available in 
Brannsether et al. (141). 
The WC was measured with a non-stretch tape on bare skin in a horizontal 
position at the mid-point between the lowest rib and the top of the iliac crest. The 
measurement was read from the side at the end of normal expiration and recorded at 
the nearest millimetre. All measurements were performed only once. 
3.7 Questionnaire 
A parental questionnaire was distributed to all participants in the BGS2 (n = 667), 
except those in the test-retest study, and to all participants in the BGS1 (n = 1524).  A 
total of 510 (74%) girls from the BGS2 and 958 (64.5%) participants in the BGS1 
returned the completed questionnaire. Data on chronic illnesses, parental educational 
level and parental ethnical origin were retrieved from similar questionnaires in both 
studies. The educational level was categorized as low (primary school), medium 
(secondary school, e.g. college) or higher (more than 12 years of education). The 
BGS2 questionnaire also contained a question about the timing of menarche, which 
was used when the girls could not recall the date themselves. 
3.8 Quality control 
The equipment was checked in the morning before every session. A test-re-test study 
was conducted every six months during the BGS1 to standardize the measurement 
technique and also to assess the observer reliability of the anthropometric 
measurements. The results from these sessions have been published for length, height 
(144), skinfolds (141) and WC (147). The measurement error was expressed as the 
technical error of measurement (TEM=√(∑d2 /2N) (where d represents duplicate 
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measurements across all observers, and N is the number of duplicates), which was 0.28 
cm for height, 0.80 cm for TSF, 0.64 cm for SSF and 0.80 cm for WC. 
3.9 Statistical methods  
An overview of the samples, variables and statistical methods for each analysis is 
provided in Table 2. A more detailed description of the statistical methods is given 
below and is also provided in the respective papers. The statistical analysis was mainly 
carried out using the IBM Statistical Package for the Social Sciences (SPSS) Statistics, 
versions 24, 25 and 26 (IBM Corp, Armonk NY, 2016, 2017 and 2019, respectively) 
and R version 3.5 (R Foundation for Statistical Computing, Vienna, Austria, 2018).  
The SDS for anthropometric measures (BMI, WC, SSF and TSF) were 
calculated according to the Norwegian growth references, which were derived from 
the BGS1 (141, 143, 144). Underweight (thinness), overweight and obesity were 
defined according to the International Obesity Task Force (134) and Cole et al. (133). 
Measurements with an SDS outside +/-3 SD were checked and excluded if clearly 
erroneous.   
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Table 2 An overview of the material and statistical methods used in the three 
papers of this thesis. 
 Paper I: Observer 
agreement (test-retest 
study) of the 
ultrasound 
examination of the 
breast 
Paper II: Pubertal 
references and 
method comparisons 
of ultrasound and 
Tanner staging of 
breast development 
Paper III: Timing of 









BGS2 (2016 and 
2017) and  
BGS1 (2003–2006) 
BGS1 
(2003 to 2006) 
Study population 
(n) 
57 girls 703 (BGS2) 
1481 girls (BGS1) 
 
1481 girls 
Median age (range) 10.9 (6.1–15.9) 10.7 (6.1–16.2) 11.8 (8–15.5) 









Kaplan Meier  
GLM (probit) 
Main variables  US B 
Depth and diameter of 



















Abbreviations: BGS1 and BGS2: Bergen Growth Study 1 and 2, BMI: body mass index, 
GAM: Generalized Additive model, GLM: Generalized Linear model (probit), IOTF: 
International Obesity Task Force, SDS: standard deviation scores, SSF: subscapular skinfold 
thickness, Tanner B: Tanner breast stage, Tanner PH: Tanner pubic hair stage, TEM: 
technical error of measurement, TSF: triceps skinfold, US B: ultrasound-based breast stage, 
WC: waist circumferences. 
 
3.9.1 Observer agreement  
Continuous and categorical data require different approaches to determine the degree 
of agreement either within or between observers. In this study, we used the Cohen’s 
kappa for categorical variables and a Bland-Altman analysis for the continuous 
measurements.  
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Agreement: Cohen’s kappa (categorical data)  
Cohen’s kappa is a widely used statistic for observer agreement of categorical 
outcomes like breast development (37-41, 148), as well as in the radiological field 
(149, 150). Kappa is a measure of the difference between the observed agreement 
(percentage agreement/concordance) and the agreement that could be obtained due to 
chance alone. The coefficient gives a measure between 0 (observed agreement does 
not exceed the agreement by chance) and 1 (perfect agreement) (151). According to 
Landis and Koch (151), the coefficient is interpreted as poor when ≤ 0.2, fair when 
0.21–0.40, moderate when 0.41–0.60, good when 0.61–0.8 or very good when 0.81–
1.0. The amount of disagreement between ordinal outcomes (e.g. a difference of 1, 2, 
… stages) can be accounted for by assigning weights. For the analysis of observer 
agreement of US staging and the method agreement with Tanner B staging (five 
ordinal levels each), we used the Cohen’s kappa with the linear weights. The Kappa 
coefficient was reported with a 95% confidence interval (CI). Agreement of the 
dichotomized classification of breast development as pubertal (US B2–5 or Tanner 
B2–5) or pre-pubertal (US B0 and B1 or Tanner B1) was tested with a simple 
(unweighted) Cohen’s kappa coefficient. 
Bland-Altman Plot  
Bland-Altman mean-difference plots were used to analyse the observer agreement of 
the (continuous) measurements of glandular depth and diameter by one (intra) and two 
(inter) observers (152). The Bland-Altman plots show the difference between the two 
repeated measurements (either by the same observer or by different observers) on the 
y-axis against the mean of both measurements on the x-axis (‘difference against the 
mean’). The mean value was used because the true value is assumed to be unknown 
(152). One-sample t-tests were used to test if the pairwise differences were 
significantly different from zero, which would indicate bias. The 95% limits of 
agreement (mean difference ± 1.96 SD of difference) indicate where 95% of the 
measurement differences are located (152). The mean difference and upper and lower 
limits of agreement are typically marked with a horizontal lines in the mean difference 
plots. The same method can be used to examine differences between two 
measurements by the same observer, two different observers or two methods that 
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measure the same quantity (153). An acceptable level of variance should be pre-
defined (152), and this threshold was set to 15% of the actual measurement in our 
study. 
In Paper I, we also calculated the technical error of measurement (TEM) by 
dividing the SD of the differences by √2 (154). The TEM is the standard deviation 
(measurement error) of a single measurement. Both the Bland-Altman plot and the 
associated limits of agreement and the TEM provide an idea of how far the 
measurements may be from the true value, which is highly relevant information. 
3.9.2 Logistic regression and Cox proportional hazards 
Logistic regression was used to test for differences in the occurrence of the four 
pubertal markers (US B2, Tanner B2, Tanner PH2 and menarche) between Norwegian 
and non-Norwegian girls adjusted for age. Likewise, the occurrence of menarche in the 
BGS1 (2003–2006) and BGS2 (2016) studies was also tested with logistic regression, 
adjusting for age, BMI SDS and parental education level. The aim of this analysis was 
to investigate if the occurrence of menarche (by age) was significantly different 
between the studies. Only girls with a documented Norwegian or Nordic origin were 
included in the latter analysis to avoid interference from the diverse ethnic background 
of the girls. The outcomes of these analyses are given as (adjusted) odds ratios (ORs) 
with 95% confidence intervals. 
In Paper III, the association between the weight-related anthropometric 
measures and the age at menarche was analysed using Cox proportional hazards 
models. The Cox regression uses the reported age at menarche and allows for 
censoring if menarche has not yet occurred at the time of study. The advantage of this 
approach is that more information is used, but it can only be applied when the age at 
transition is known (e.g. menarche but not B2, PH2). The anthropometric predictor 
variables (BMI, WC, SSF and TSF) were classified according to their SDS as low (< - 
1 SDS), normal (-1 ≤ SDS ≤ 1 SDS) or high (> + 1 SDS), and ‘normal’ was used as the 
reference category to which both ‘low’ and ‘high’ were compared in the analyses. We 
reported results from unadjusted simple Cox regression models for each marker 
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separately, as well as fully adjusted multiple regression models in which the effect of 
all anthropometric measures is jointly estimated and final models, which are the result 
of a stepwise (backwards) removal of statistically non-significant predictor variables. 
A p-value below 0.1 was used as a removal criterion, but only factors with a p-value 
below 0.05 are considered statistically significant. The results are expressed as hazard 
ratio’s (HRs) with 95% confidence intervals, which indicate the probability of having 
menarche at a given age according to the grouping level of a covariate (e.g. ‘high 
BMI’) relative to the reference category (‘average BMI’). The fully adjusted and final 
models allowed to estimate the effect of anthropometric variables independent of the 
other (somewhat correlated) variables. Because of the possibility that girls may have 
had a different weight status at the time of examination and at the time of menarche, 
all analyses were repeated in a subgroup of participants who had experienced 
menarche during the 12 months prior to investigation.  
In Paper III, the median ages at menarche for all girls, and then also girls in 
different weight classes were estimated with Kaplan-Meier analysis. Similar to the 
data sampling for Paper II, the occurrence of menarche implies left censored variables, 
girls that have not yet experienced menarche were right censored.  
3.9.3 References for the age at entry of pubertal markers  
Reference ranges for pubertal development are based on the cumulative distribution of 
ages at entry into the various puberty markers/stages (US B, Tanner B, Tanner PH 
stages and menarche). The cumulative distribution was estimated from the age and 
current status of the girls with either probit regression (a generalized linear model with 
probit link function) or with a generalized additive model (GAM) for binary outcomes 
with probit link. These two statistical methods differ by the assumption of a normal 
distribution of ages (probit regression) or not (GAM). The age reference curves were 
estimated for each stage of each marker separately with both the probit and GAM 
analyses. The degree of smoothing of the GAM was determined by generalized cross-
validation, and all models were checked with diagnostic plots using the mgcv package 
in R (155) (version 3.5, R Foundation for Statistical Computing, Vienna, Austria, 
2018). The probit model has the advantage that the whole age distribution is 
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characterized by the mean and SD, but the validity depends on a normal (Gaussian) 
distribution of ages. In the tables and text, we primarily reported numbers from the 
nonparametric additive model, because few age distributions were found Gaussian. 
Probit analysis was also used to estimate the mean and SD of age at menarche in 
BGS1, both for the whole group, and for the sub-group of girls who had experienced 
menarche during the 12 months before the measurements were performed (‘girls with 
recent menarche’). 
3.9.4 Power calculations 
The initial aim of the BGS2 was to recruit 100 girls per age stratum from 6 – 16 years 
of age (i.e. a total of 1000 girls) for the construction of pubertal references. Due to the 
time required for the examination of individual girls, the difficult recruitment of 
children for a puberty study and the logistical challenges, we did not reach this target 
number of participants. Some dropouts or missing responses were, however, expected, 
and the current sample size allowed us to estimate the median age at the transition 
from a particular stage of pubertal development to the next (e.g. menarche, or from B2 
to B3) with a standard error of about one month, and the outer limits of the ‘normal 
range’ (-2 to + 2 SD) with a standard error of 2–3 months, which was considered 
sufficiently precise. 
The sample size of the BGS1 was estimated for the purpose of detecting secular 
changes in height and weight during a 30-year period (117). A post hoc power analysis 
for Paper III showed that the sample allowed us to detect statistically significant 
hazard ratios of approximately 1.3 for all girls and 1.5 for the 181 girls with recent 
menarche. 
3.10 Ethics 
Parental consent and participant assent were obtained before the children were 
enrolled in the study (consent letter in Appendix). Participants who withdrew their 
assent were omitted (approximately 5 girls in the BGS2). All children received age-
appropriate information in writing and also verbally by the study nurse prior to their 
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participation. The BGS1 and BGS2 were approved by the Regional Committee for 
Medical and Health Research Ethics in Western Norway (BGS1, REK number 09740 
and for BGS2, 2015/128/REK Vest). The studies complied with the Declaration of 
Helsinki (156).  
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4. Summary of results 
4.1 Paper I 
Paper I was a methodological paper that investigated the agreement both within and 
between observers when using ultrasound to assess breast development throughout 
puberty. Fifty-seven girls aged 6.1–15.9 years (mean age: 10.9 years) participated in 
this study. The intra-observer comparison (for one observer, ISB) of breast staging had 
a linear-weighted kappa coefficient of 0.84 (95% CI: 0.78–0.91), and 70.2% (40/70; 
95% CI: 56.4–81.2%) concordance, respectively, and the inter-observer (nurse vs. 
specialist) comparison demonstrated a kappa coefficient of 0.71 (0.62–0.80) and a 
concordance of 51.8% (29/56; 95% CI: 38.1–65.2%) when using the six stages of 
breast development. When the two prepubertal stages (US B0 and US B1) and the 
pubertal stages (US B2 and above) were combined, perfect agreement (e.g. 100% 
concordance) was found for one observer, and 96.4% (95% CI: 86.6%–99.4%) 
concordance was calculated for the inter-observer assessments.  
For the measurements of the depth and diameter of the mammary gland, the 
mean differences between the first and second measurement of one observer were not 
significantly different from zero (one sample t-test, p = 0.86 and p = 0.070 for the 
diameter and depth, respectively), which indicated no systematic bias. For the two 
observers, the mean difference was not significantly different from zero for the 
measurements of diameters (p = 0.86), but a mean difference of 0.1 cm was found for 
the depth (p < 0.01). However, the limits of agreement were relatively wide for both 
the depth (29% of the sample mean) and diameter (45.0%). The percentages were 
found by dividing the limits of agreement (range from lower to upper) (e.g. 0.4 cm for 
the depth and 2.4 cm for the diameter for one observer) by the average depth and 
diameter. A constant variance across the range of measurements was observed in the 
Bland-Altman plots (shown in the supplemental material of Paper I). 
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4.2 Paper II  
Reference ranges for the timing of pubertal development are represented in Paper II 
(Table 3). The pubertal references were based on 696 girls for US B, 700 for Tanner 
B, 372 for Tanner PH, and 643 for menarche. The median (p3, p97) age at onset of 
breast development was 10.2 (7.8, 12.6) years according to ultrasound staging (US 
B2), and 10.4 (8.2, 12.6) years according to Tanner staging (B2). The median (p3, 
p97) age at Tanner PH2 was 10.9 (8.18, 12.58) years, while that of menarche was 12.7 
(11.0, 15.9) years. Ultrasound breast staging (US B) indicated an earlier age at 
pubertal onset (0.2 years) compared to the Tanner method, while the opposite was 
found for the higher maturational stages (Tanner B4 and B5) where the age at 
transition with Tanner staging was ahead of the ultrasound assessment.  
The ultrasound and Tanner methods had a good overall level of agreement 
(kappa = 0.87 (95% CI: 0.85–0.89)) and were concordant in 551 of 695 (79.3%) 
assessments. When dichotomising the breast developmental stage into thelarche (B2 or 
higher) or not thelarche (US B0/B1 or Tanner B1), the agreement was very good 
(kappa = 0.94 (95% CI; 0.91–0.96)). The kappa coefficients were comparable in girls 
with average weight (kappa = 0.88 (95% CI: 0.86–0.91)) and overweight/obesity 
(kappa = 0.85 (95% CI: 0.79–0.90). 
The onset of all pubertal markers in the BGS2 occurred earlier in girls with a 
known non-Norwegian origin (n = 92) compared to girls of a known Norwegian origin 
(n = 374). A comparison with the BGS1 demonstrated that the occurrence of menarche 
had significantly decreased from 13.3 (SD 1.7) years in 2006 to 13.1 (SD 1.2) years in 
2016 (p < 0.05) in Norwegian girls (Figure 4). This difference remained statistically 
significant (OR: 2.0; 95% CI: 1.1–3.6; p = 0.016), when additionally adjusted for the 
BMI SDS and parental educational level.  
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Table 3 Age references for breast development, pubic hair and menarche: 
the median and distribution (-2, -1, 1, 2 SD) of the age (in years) at 
attainment of the specified stage.  
  Generalized Additive Model 
Age at attainment 
 Probit 
Pubertal marker  -2SD -1SD Median 1SD 2SD  mean (SD) age 
Breast (ultrasound)         
 US B1  NA 5.6* 8.3 10.7 12.4  8.3 (2.2) 
 US B2  7.7 8.9 10.2 11.5 12.8  10.2 (1.3) 
 US B3  9.1 10.3 11.5 12.7 13.9  11.5 (1.2) 
 US B4  10.4 11.3 12.3 13.9 NA  12.7 (1.5) 
 US B5  11.3 12.7 15.9 NA NA  15.3 (2.3) 
Breast (Tanner)          
 B2  8.0 9.2 10.4 11.6 12.7  10.4 (1.2) 
 B3  9.5 10.4 11.4 12.5 13.8  11.5 (1.1) 
 B4  10.7 11.6 12.5 13.8 NA  12.8 (1.3) 
 B5  11.1 12.3 14.7 NA NA  14.8 (2.2) 
Pubic Hair (Tanner)     
 PH2  8.5 9.7 10.9 12.1 13.3  10.9 (1.2) 
 PH3  9.7 10.9 11.9 12.9 13.7  11.9 (1.1) 
 PH4  10.5 11.8 13.1 14.4 15.7  13.1 (1.3) 
 PH5  11.4 13.0 15.1 NA NA  15.1 (1.9) 
Menarche  11.0 11.7 12.7 14.1 16.2  12.9 (1.2) 
Abbreviations: NA: not available (outside the data range); SD: standard deviation; US B: ultrasound-
based breast stage, B: breast; PH: pubic hair * extrapolated age that falls just below the data range. The 




Figure 4. The cumulative proportion of girls who had reached menarche by 
age estimated with a generalized additive model for binary data with a probit 
link. Data from girls of Norwegian or Nordic origin in the studies from 2006 
(BGS1) and 2016 (BGS2). Grey areas indicate the standard errors 
below/above the estimated age prevalence. The figure is similar to 
Supplemental figure 3 in Paper II and has been reprinted with permission. 
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4.3 Paper III  
In Paper III, we explored the association between the age at menarche and weight-
related anthropometric measurements (BMI, WC, SSF and TSF) in the BGS1. A total 
of 477 of 1481 (32.2%) girls had experienced menarche, and 181 had done so during 
the last 12 months before the data collection. The overall mean age at menarche was 
13.3 years (95% CI; 13.1-13.4, SD 0.9 years). We demonstrated that both high (> 1 
SDS) and low levels (< -1 SDS) of all weight-related anthropometric variables were 
significantly associated with earlier and later menarche, respectively, when compared 
to the girls with normal levels (-1 ≤ SDS ≤ 1) in the unadjusted models. In a fully 
adjusted analysis of all the measurements together, only a high BMI was significantly 
related to earlier menarche (HR 1.41, 95% CI: 1.07–1.85), and both low BMI and low 
SSF with later menarche (HR 0.53 95% CI: 0.38–0.75 and HR 0.54, 95% CI 0.39–
0.75, respectively). Similar results were found when using the IOTF classification of 
weight status. In girls with recent menarche, only a high BMI was significantly 
associated with an earlier age at menarche (HR 1.79, 95% CI: 1.23–2.62), but this 
analysis may have lacked sufficient statistical power because of the small sample size.  
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5. Discussion  
In this thesis we have investigated a new method to assess puberty in girls based on 
utrasound examination of the breast. Utrasound staging was found a reliable 
alternative for traditional Tanner staging. Further we have developed a framework to 
evaluate utrasound staging of the breast by estimating age-references which show the 
typical distribution of maturity by age in healthy girls living in Norway. Further we 
could document that the age at menarche has again decreased in girls of Norwegian 
origin. Finally we have demonstrated that the age at menarche is related to weight 
status in girls. 
5.1 Methodological considerations  
When investigating pubertal development with the aim to estimate pubertal references, 
the sample of participating children and adolescents should be representative of the 
target population. This implies that a population-based sample is preferable. However, 
selection bias may arise when the study population differs from the general population 
in relation to factors either known or unknown to influence the outcome: in this case, 
normal pubertal onset and development. In this section, potential biases related to 
participation, generalizability and selection will be discussed. 
5.1.1 Participants and study design 
Participation and generalizability 
The design, recruitment and target populations were similar in the BGS2 and BGS1. 
Non-participation is a challenge in most, if not all, population studies. The overall 
participation rates were 50.3% in the BGS 2 and 67% in the BGS1. Higher 
participation rates were observed among primary school children (from 6–12 years of 
age) than they were in upper secondary school in both studies (compared in Table 2). 
The BGS2 was the first pubertal reference study conducted in Norway. Earlier 
Norwegian studies that reported data on pubertal development have either included 
data on menarche only, or documented Tanner stages from datasets with a limited age 
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range without estimating the ages at onset (63, 157-159). The published references in 
Paper II are the first to be based on a Norwegian sample, and also the very first 
references for ultrasound breast staging. The participation rate of 50.3% may seem 
rather low when representativeness of the target population is aimed at, but it is 
comparable to studies including physical assessments of pubertal development in other 
European countries with reported rates from < 40 to 80% in the Netherlands (160), and 
better than the rates reported in the Copenhagen Puberty Study in Denmark (~ 40% 
(27) and ~35 % (72)). There were only a few missing observations for the US B and 
Tanner B assessments (98.9 % and 99.6% consented, respectively), while the 
assessment of pubic hair included 82% of the girls who were asked.  
National growth reference curves for height, weight, BMI, skinfolds and WC 
have previously been published based on data from the BGS1, and the study is 
regarded as nationally representative. Possible selection bias was examined among 149 
non-participants in BGS1 and revealed no statistically significant difference in the 
prevalence of overweight and obesity between those who participated and those who 
did not (144). However, selection bias could not be ruled out based on this sub-study 
as the participation rate was 38%. The similar prevalence of overweight and obesity 
documented in other population-based samples from the same time period strengthens 
the case of generalizability in terms of weight-status for the BGS1 (161, 162). The 
prevalence of overweight (including obesity) was 14.6% in BGS2 participants and 
very similar to data from the girls aged 8 to 15.5 years in BGS1 (14.3%) (163). A 
population-based study of 8- to 9-year-old Norwegian girls, found a slightly higher 
prevalence of overweight and/or obesity of 17% in 2015 (164). Regarding the 
prevalence rate of overweight and obesity we believe that our sample is fairly 
representative of the current Norwegian female child population.   
The difference in participant rates between the BGS1 and the BGS2 may be 
partly attributable to their different aims, (i.e. puberty vs. normal growth and 
development). One can speculate that girls with late or early puberty compared to their 
peers may not have consented to participate or that some girls were reluctant to 
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participate due to being unhappy with their physical appearance in general. These are 
potential sources of a self- selection bias that most pubertal studies will encounter.  
Socioeconomic status  
A recent survey of living conditions from 2016 found that the Bergen municipality is 
overall very similar to the rest of the Norwegian population in terms of its 
socioeconomic structure (165). Parental educational level has been shown to be a valid 
variable for socioeconomic status in Norway (166). The prevalence of parents with a 
higher level of education was 79.6% in the BGS2 versus 62.4% in the BGS2, 40.4% in 
the population in Bergen in 2016 (167) and 34.1% in the general Norwegian 
population (168). Overrepresentation of participants with a higher education level has 
been reported in other studies as well (169-171). In the BGS1, the prevalence of 
overweight (including obesity) was higher in children of parents with a lower 
educational level (22% vs. 14%) (172). A similar trend was found in the BGS2 (19% 
vs. 11%, unpublished data). However, we could not find evidence that that the parental 
education level had a statistically significant impact on the occurrence of menarche in 
either the BGS2 or BGS1, which is in line with the findings of other relevant studies 
(34, 67, 105, 173).  
Ethnic origin 
The study population from BGS2 reflects the overall composition of ethnicity/race in 
the population of Norwegian girls in 2016 (Table 4 (174)), and data from all girls were 
included in the estimation of references. Although this approach might increase the 
applicability of the references in the Norwegian population as a whole, it could also be 
challenging to compare with follow-up studies with other ethnical compositions. 
Differences in pubertal timing according to ethnicity are well-known (33) which is 
why we also carried out analysis stratified for parental origin to test the potential 
impact on our data. There was a tendency for earlier puberty in non-Norwegian girls, 
but exclusions based on ethnicity had only minor impact on the lower cut-offs (-2SD) 
for defining precocious puberty (breast development before the age of 8.0 years 
including all ethnicities, and 8.1 for girls with a known Norwegian origin (not 
published)). When studying changes in the timing of menarche from BGS1 to BGS2, 
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only girls with a Norwegian origin were included to avoid interference from changes 
in the ethnic background. Girls with a Nordic origin (1.5%) were also included in the 
sample from the BGS1 because the Nordic girls were included in all growth references 
from the BGS1. 
 
Table 4 The origin of non-Norwegian girls in the study sample and in the 


















       
6-15 years 5.9 % 3.1% 5.8 % 0.1 % 0.3% 0.01% 9.4% 
In the 
BGS2 
       
6-16 years 5.7 % 2.6% 6.4% 0.0% 1.5% - - 
 
Chronic illness 
Girls with known chronic illnesses likely to affect growth and development were 
excluded. However, any participant with a chronic illness who did not complete a 
questionnaire that disclosed such information may have been included. Girls with 
chronic illness are known to enter puberty later (97), and this may have influenced our 
estimates towards later ages. However, the exclusion/inclusion of children with known 
chronic illness showed non-significant and inconclusive results, but the numbers were 
very small.  
To conclude, we believe that the participants in Paper II are fairly representative 
of the contemporary population of children and adolescents in Norway with respect to 
ethnicity and weight status. Although the socioeconomic status of BGS2 participants 
was higher, this potential difference did not seem to impact on our results. Thus, we 
believe the data can reliably indicate the pubertal timing and may be generalized to the 
whole of Norway.  
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5.1.2 Ultrasound procedure 
In Paper I, the ultrasound procedure (staging and direct measurements of glandular 
breast tissue) was performed two times by the main observer (ISB). It may be argued 
that the 20 to 35 minutes interval between examinations was not sufficient to exclude 
recall bias for the intra-observer agreement. However, all 57 girls in the test-retest 
study were examined over three busy days, which implies a large amount of similar 
measurements were obtained within a limited time frame. For this reason, we believe 
that the risk of recall bias was small, although it cannot be entirely excluded. In terms 
of external validity, it is of note that the results for agreement in this study may be 
different for other observers in other settings, due to factors such as the experience and 
training of the observers (175). Thus, a limitation of our test-retest study was that the 
assessments were performed by two observers only. However, a study including more 
than two observers would have posed an added burden on the participating girls and 
also introduced some logistical challenges.  
Tanner B assessments by ISB were included in the examinations of each girl in 
Paper I and Paper II. The Tanner B assessments were done prior to the investigation 
with ultrasound which may have introduced a systemic bias toward better agreement 
between ratings. Ideally, the assessments of breast development by ultrasound should 
have been done by someone who was blinded for the Tanner B examination. However, 
the Tanner B assessments were done blinded for the examinations with ultrasound, and 
the recorded Tanner B stages were not changed ‘retrospectively’. A second scoring 
session where ISB re-scored 122 ultrasound images blinded for previous scorings, 
found a good agreement of 0.76 between the initial and new ultrasound stages. In a 
clinical setting, an observer performing ultrasound assessment is not likely to be 
blinded for the visual appearance of the breasts either. We believe that the preceding 
Tanner B assessment and postponed staging procedure did not have a large impact on 
our results regarding ultrasound breast staging, although this cannot be ruled out. 
Characterizing pubertal breast development with ultrasound  
Six distinct ultrasound-based stages were described in Paper I. Systems created to 
characterize biological features may be challenging due to inter-individual variations 
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in appearances, i.e. that the observed morphological appearance does not necessarily 
‘fit’ into a predefined scheme/protocol. In our study we found it necessary to establish 
two stages that were assumed to be prepubertal to accommodate the different 
appearances. Since ultrasound can only assess the appearance and not the nature of 
tissues, we were not able to determine potential physiological differences between US 
B0 and US B1. It is, however, reasonable to believe that the white areas on the image 
in US B1 contain more/different amounts of fat as compared to the small, dark area 
that defines US B0. 
Direct measurements 
We used a 5-cm long linear transducer for all ultrasound assessments in Papers I and 
II. For all diameters larger than 5 cm but less than 10 cm we combined the results of 
two scans. Extending this procedure for diameters of more than 10 cm to capture the 
whole breast diameter was considered too difficult to do in a reliable and standardized 
way without introducing a high degree of measurement error. While the truncation at 
10 cm would be an important aspect to consider when presenting descriptive data on 
diameter (or volume) of glandular tissue in more mature breasts, we do not believe that 
it is a major problem for the purpose of Paper I because the Bland-Altman plots 
showed that measurement errors were largely independent of size (at least up to 10 
cm).  
5.1.3 Tanner staging 
The pubertal assessments of breast and pubic hair development in Paper II was based 
on Tanner staging. According to recommendations from reviewers and expert 
opinions, we included breast bud palpation into the Tanner B staging (2, 35). Ideally 
we should have included an assessment of observer agreement of Tanner B and PH 
staging as well, but the focus of our study was on ultrasound assessment. The skill of 
the observer is important when assessing breast development, and observer agreement 
for Tanner B staging has shown to be highly variable (39-41). However, not all studies 
specified whether breast bud palpation was used, and the intra-observer agreement was 
rarely tested. Due to the cross-sectional design of our study, we do not know if girls 
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had transient thelarche, which has been shown to be a relatively frequent phenomenon 
(12%) in one Danish study (176). 
Tanner B staging including palpation was validated against MRI in 100 healthy 
girls, and the study concluded that the method could reliably detect glandular breast 
tissue development (25). The study nurse in our study (ISB) received training by an 
experienced paediatrician before the examinations. In addition, the drawings and 
descriptions of the Tanner B stages were always available for the observer. We believe 
that this step improved the validity of the assessments. The issue of intimate shaving 
practices came up frequently, and may have biased the assessments of the Tanner PH 
stage, in particular the higher stages (and thus ages). However, the visual inspection 
gives a fair idea of how widespread the pubic hair development is and where the 
‘hairline’ stops.  
5.1.4 Menarche  
Data on the occurrence (yes/no) of menarche from BGS2 and BGS1 was used in 
Papers II and III, while recall age (year/month) from BGS1 was also used in Paper III. 
In the BGS1, girls with visual signs of breast development were asked for occurrence 
and recalled age at menarche, while all girls in the BGS2 were asked. The accuracy of 
the recalled age at menarche is probably dependent on the recall interval, with a higher 
accuracy for shorter intervals (177). The time since menarche varied from 1 day to 4.7 
years in the BGS1. Possible recall bias was tested by comparing the probit mean age 
found in all girls and in the group of girls with recent menarche (during the last 12 
months) in Paper III, and we found only a small difference (0.1 year). Thus, we expect 
our data on menarche to be valid. Descriptive age references for menarche were based 
on status quo data in Paper II. 
5.1.5 Anthropometric measurements 
In the BGS2, the same nurse performed all anthropometric measurements (height and 
weight used in this study). The observer agreement in performing the anthropometric 
measures was tested in test-retest studies in BGS1 and found to be satisfactory. Both 
the WC and skinfold (178) are regarded as technically difficult assessments, and the 
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limited number of trained observers is therefore considered a strength of these 
procedures. 
5.1.6 Questionnaire data 
The response rate for the questionnaire data in the BGS1 and BGS2 were relatively 
good, with rates of 67% in the BGS1 and 75.7% in the BGS2. In Paper II, 
questionnaire data were used to obtain information about parental ethnic origins, 
chronic illness, parental educational level, and the girl’s occurrence of (and age at) 
menarche. 
5.1.7 Age range 
The inclusion of girls from 6 years and onwards was sufficient to cover the age where 
no girls had yet started breast or pubic hair development. The inclusion of girls above 
16 years would probably have improved the precision (with a smaller statistical 
uncertainty) of our estimates of the ages when girls attained stages 4 or 5. Including 
girls above this age would also have required data sampling in high schools, and our 
priority was instead to cover the stages nearer to the pubertal onset.  
5.1.8 Statistical considerations 
Cross-tables were included to show agreement of repeated measures of ultrasound 
staging in Paper I and agreement of different methods in Paper II. These tables were 
included because the kappa coefficient does not provide information about the nature 
of the disagreements, such as whether they appear systematic. This is visualised in 
cross-tables. 
Generalized additive models (GAM) are extensions of generalized linear models 
(GLM). These nonparametric models are very flexible and do not depend on a 
predefined shape (e.g. logistic, probit, linear) of the curve, but are also more 
susceptible to overfitting, and extrapolation beyond the range of actual observations 
should be avoided. To avoid overfitting, we relied on cross-validation to determine the 
degree of smoothing, and visually inspected smoothness of the GAM curves and fit of 
the data (observations) together. Extrapolated age estimates outside the data range 
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were omitted from the tables when they occurred before the age of 6 or above the age 
of 16 years (Table 1 in Paper II).  
Data on anthropometric measurements and the occurrence of menarche were 
collected at the same time in BGS1, and menarche could have occurred years before 
the measurements were taken. This introduced methodological challenges in paper III 
because the measurement were not obtained at the same time point as menarche. An 
increase or decrease in anthropometric measurements may have happened after 
menarche. Additional analyses showed that the same pattern of associations was found 
for girls who had experienced menarche during the last year, i.e. close to the actual 
measurement. A similar approach has been used in other studies, with also similar 
results in both groups (67).  
5.1.9 Ethical considerations  
Ethical issues arise when inviting children to participate in research. The Declaration 
of Helsinki states that ‘no individual capable of giving informed consent may be 
enrolled in a research study unless he or she freely agrees’ (156). In this study, we 
performed examinations that may be perceived as intimate. The children were 
informed about their individual right and also their ability to withdraw at any time 
from the examinations independently of their parents’ consent for participation. All 
children were rewarded with a cinema ticket for their participation, but were not 
further encouraged or persuaded to participate if there was doubt about their consent. 
5.2 Discussion of results  
5.2.1 Observer agreement 
To establish a relatively new method to determine breast development and to estimate 
the associated reference values, we had to document observer error. We did this by 
evaluating the intra- and inter-observer agreement. We have used the term agreement 
when referring to the testing and quantification of how close two assessments were 
when performing ultrasound-determined morphological staging and/or when 
performing direct measurements of the same breast by one or two observers (175). We 
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also used agreement when referring to the comparison of the two methods (US B and 
Tanner B) used to assess pubertal breast development (Paper II). However, 
repeatability of the ultrasound method was only tested in Paper I.  
According to the common interpretation of kappa values (151), our ultrasound 
scoring system performed ‘very good’ for one (kappa 0.81; 95% CI 0.78–0.91), and 
‘good’ (kappa 0.71; 95% CI: 0.62–0.80) for two observers when using the ultrasound 
scoring system. Comparisons of the kappa coefficients only between studies are of 
limited interest, because they are dependent on the distribution of stages (179), which 
is rarely reported, and different inclusion criteria are applied in the studies (age range, 
level of maturation, clinical assessment or photos, etc.). With these limitations in 
mind, we compared our results with earlier studies that tested the inter-observer 
agreement in Tanner B staging and found kappa values that varied between 0.50 (n = 
25) (41), 0.67 (n = 127) (37), 0.78 (n = 22 and n = 20) (38, 39), and 0.86 (n = 56) (40). 
The kappa values kappa values achieved in our study were similar or higher compared 
to most of these previous studies that tested observer agreement. The main 
discrepancies between observers were between the two prepubertal stages (US B0 and 
US B1), and merging these two stages (and therefore making the scale more similar to 
the Tanner B system with five stages) did improve the kappa coefficient for intra- 
(kappa from 0.81 to 0.85) and inter- (kappa from 0.71 to 0.78) observer agreement 
slightly. Because merging these stages had a limited impact on the kappa coefficient, 
we chose to use both when comparing the staging with ultrasound with the staging 
according to Tanner B in Paper II.  
Further, we demonstrated that one and two observers had very good 
concordance, (i.e. corresponding scores), when determining if breast development had 
started or not with ultrasound (US B0/US B1 vs. US B≥2). According to existing 
literature that questioned the reliability of Tanner B staging to determine whether 
breast development had started or not, detection of this transition may be the most 
important advantage of new methods. Nevertheless, Paper I provides novel and 
previously unavailable data on observer agreement when using ultrasound to stage 
breast development, so no other studies are available for a direct comparison. Because 
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the kappa values were good and the difference between assessments was rarely more 
than one stage within (n = 1) or between observers (n = 4) in Paper I, we reasoned that 
all six stages could be used reliably to characterize pubertal breast development with 
ultrasound.   
The measurements of glandular size obtained by one and two observers were 
found to have no or small systematic differences but were imprecise. The variance for 
both depth and diameters seemed homogeneous across all measurements, and implied 
that the difference between measures was relatively smaller for larger depths and 
diameters than for the smaller depths and diameters. We concluded that we could not 
use the direct measurements in our study.  
5.2.2 Method comparison 
In Paper II, ultrasound staging of glandular tissue was further investigated by 
comparing it to the standard Tanner B method used to assess breast development. We 
found a high level of agreement between the two methods in determining pubertal 
onset (kappa 0.94; 96% CI: 0.9-0.96). We suggested, in Paper I that using two 
prepubertal ultrasound stages could potentially allow the detection of early signs of 
breast development during the prepubertal period. When investigating the different US 
B stages within the prepubertal Tanner B1 (n = 313), we found that 166 (53%) girls 
had US B0, 129 (41.2%) girls had US B1, and that 18 (5.8%) girls were classified as 
having US B2, indicating a pubertal appearance of glandular tissue with ultrasound. In 
contrast, 3 (3.8%) girls had signs of pubertal breast development according to Tanner 
B staging (Tanner B≥2) with no glandular breast tissue visible on ultrasound (US B0 
or US B1). When estimating the age references, there was a difference in median age 
between the methods, with ultrasound-determined pubertal onset (US B≥2) being 0.2 
years earlier than that identified with Tanner B≥2. This result was opposite of what we 
expected based on the literature, which suggested that Tanner B staging, particularly 
without palpation, may overestimate the appearance of breast development (180, 181). 
On the other hand, ultrasound allows to directly observe the glandular tissue and may 
(theoretically) allow to detect small psysiological changes before they become 
apparent by visual inspection. In a recently submitted paper, we found that the girls 
 62
with Tanner B1 and US B≥2 (of who 14 girls with blood samples), was associated 
with significantly higher levels of E2 compared to girls with (prepubertal) US B0 or 
US B1 (182). 
We were, however, expecting to find prepubertal breast tissue with ultrasound 
in a higher number of girls that were assessed as pubertal with Tanner B (Tanner B≥2). 
This was not the case, and only happened in three cases. Although our hypothesis was 
related to all girls, we thought that particularly girls with overweight would be 
classified as pubertal with Tanner B and prepubertal with ultrasound. The overall 
prevalence of girls with overweight and obesity was, however, low, and none of these 
(three) girls had overweight or obesity. 
In the studies that have applied ultrasound to stage breast development, 
inclusion has mostly been based on the visual appearance of breast development (by 
parents) or appearence of breast development according to Tanner B staging (by 
clinicians) (42, 53-55), i.e. included girls that had entered puberty. Therefore, these 
previous findings comparing the ultrasound and Tanner B staging around the time of 
pubertal onset is of limited value with respect to our unexpected findings. However, 
Bruni et al. (26) performed both Tanner B and ultrasound staging in healthy girls 
ranging from Tanner B1-B4 stages and found that 6 out of 48 girls presented with 
Tanner B1 and a ‘Stage 2’ (i.e. “first appearance of the glandular bud”). Of note, no 
report was made about palpation when assessing the Tanner B stage. In our study, all 
girls were palpated to detect the presence of glandular tissue, and we do not believe 
this unexpected discrepancy was due to assessment error.  
Previous studies that compared ultrasound-determined breast maturation with 
Tanner B stages did not find that the staging by each of the methods were necessarily 
appearing simultaneously (26, 42, 53). The two methods (US B and Tanner B) had an 
overall good agreement when determining breast maturation throughout puberty as 
shown in Paper II. However, there were several discrepancies, also for the higher 
maturational stages. For the Tanner B2 to B4 stages, both higher and lower US B 
stages were observed, indicating different grades of maturation. The methodological 
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differences were also evident when comparing the estimated median ages at attaining 
corresponding breast stages from each method. The difference varied from 0.1 years 
(for US B3 and Tanner B3) to -1.2 years (for US B5 and Tanner B5). In Paper I, we 
found that agreement within and between observers improved when dichotomizing the 
stages as prepubertal or pubertal. The morphological appearances of pubertal breast 
tissue that correspond to US B2, US B3 and US B4 may be perceived as similar, 
recognised by a subareolar hypoechoic area (Figure 2 of this thesis). Consequently, 
stages 3 and 4 have been described as coinciding in the literature (47, 183, 184). 
Merging Tanner B stages into less narrow categories such as prepubertal, in- puberty 
and (near) adult phases, has also been suggested for self-assessments of pubertal 
development with the intention to increase accuracy (185). Further, Tanner B4 and B5 
are regularly combined when reporting findings (72). This might be because both 
stages are regarded as mature, that not all girls experience Tanner B4 before B5 (1) 
and because the distinction between these two stages may be of limited clinical 
importance. However, in the aforementioned (unpublished) paper from this research 
group, we did find that the good agreement that was established by the kappa 
coefficient between the two methods was also confirmed when comparing hormonal 
values for the pubertal girls (comparing Tanner B2-5 and US B2-5), which 
demonstrated that these two methods seem to be endocrinologically comparable, 
across the whole range of stages (182).  
The observed discrepancies between the methods may not be surprising, as one 
approach is based on the outer characteristics while the other is based on the 
morphological appearances observed with ultrasound. Neither method was regarded as 
a gold standard. Therefore, we have been reluctant to propose or hypothesise that one 
of both methods misinterprets the glandular maturation but instead suggest that they 
may provide different information.  
5.2.3 Ultrasound and Tanner staging and adipose tissue  
Adipose tissue in breasts without actual breast maturation (lipomastia) is probably the 
main reason of misclassifications with Tanner B staging of breast development. This 
concern seem to be based more on ‘clinical empirical’ experiences than on 
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scientifically observed data, since only few studies have actually compared the 
observer agreement of Tanner B staging in girls with overweight and/or obesity to 
girls of a normal weight (37, 38). These studies did not find any significant 
differences.  
We observed a small difference in agreement between girls with a normal 
weight and girls who were overweight when comparing the two methods (kappa 
coefficients were 0.88 (95% CI: 0.86–0.91) and 0.85 (95% CI: 0.79–0.90), 
respectively). Full concordance between US B and Tanner B staging was found in 
81.6% and 73.4% of girls with a normal weight and overweight/obesity, respectively. 
In total, 94 out of 644 girls with a known weight status had overweight or obesity (47 
had underweight), and these girls were spread over a 10-year age span and across all 
five stages of pubertal development. We were therefore reluctant to use this limited 
group to draw conclusions on how ultrasound staging performed on girls with 
overweight vs. normal weight. However, we did find that the Tanner B staging tended 
to overestimate the breast development compared to the corresponding US B stage for 
the same breast in girls with overweight (including obesity). Increased inconsistency 
with increasing BMI has also been found in other studies comparing the ultrasound 
staging and Tanner B staging (55). Interestingly, Fugl et al. (25) observed that girls 
with an increased BMI had less glandular breast tissue (as estimated using MRI) 
compared to girls with a normal weight in the mature stages. The study suggested that 
the clinical examination could not distinguish between glandular tissue and fat in more 
mature girls and indicated that in girls with a higher BMI, the Tanner B stage may be 
overestimated. Longitudinal studies in samples emphasizing girls with normal weight 
and overweight would be ideal to find out more about how the ultrasound-determined 
breast development appears in these groups, and whether there are differences in how 
they relate to Tanner B staging.  
5.2.4 Pubertal references compared to current references 
Compared to the current pubertal references used in Norway based on Danish data 
from 1991–1993, our estimated ages at onset for breast (B2) and pubic hair 
development (PH2) and menarche were advanced by 0.5, 0.4 and 0.7 years (27), 
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respectively (Table 5). The Tanner B3 and B4 stages occurred 0.9 and 0.8 years earlier 
(27), indicating that the entire distribution has shifted towards younger ages when 
compared with current references. Danish data from the same group in 2006 also 
found that all stages of breast development occurred earlier; however, they observed a 
steeper decrease in pubertal onset (the average age at onset of the Tanner B2 stage was 
9.8 years) during a shorter time (72). Evidence suggests a larger variance for the onset 
of puberty than in the age at menarche. When comparing ages at pubertal onset with 
relevant studies from Europe, we could not find that Norwegian girls matured at 
particularly young ages (e.g. Tanner B2 at 10.7 years in Belgium (30), 10.0 years in 
Greece (73), 10.7 years in the Netherlands (31) and 10.1 years in British girls (15). 
 
Table 5 Mean ages at reaching breast and pubic hair development and 
menarche in 1100 healthy Danish girls and 703 healthy Norwegian girls 
investigated from 1991–1993 and in 2016, respectively. The results are 
presented as the mean and lower and upper bounds for the probit analyses 
for Tanner B and PH, and Generalized additive model for menarche from the 
BGS2. 
 Copenhagen Puberty Study, 
Denmark (27) (N = 1100) 
Bergen Growth Study 2, 
Norway (N = 703) 
 Mean ± 2 SD Mean ± 2 SD 
Tanner B2 10.9  8.7–13.1 10.4  8.0–12.7  
Tanner PH 2 11.3 9.3–13.3 10.9 8.5–13.3 
Menarche  13.4 11.2–15.7 12.7*  11.0–16.2 
Abbreviations: Tanner B2: Tanner breast stage 2; Tanner PH 2: Tanner pubic hair stage 2; 
SD: standard deviation. *median age at menarche 
 
5.2.5 Secular trend in the age at menarche 
Considering the increased prevalence of paediatric overweight and obesity in Norway 
during the 30 years preceding the BGS1 (117), a lower age at menarche would not be 
unexpected due to the suggested association between overweight and earlier pubertal 
timing. However, the age at menarche had remained relatively stable just above 13 
years in the BGS1 (Paper III). A trend with a stable age at menarche despite an 
increase in the prevalence of overweight has also been found in e.g. Germany and 
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Belgium (30, 67). However, a statistical significant decline in age at menarche of 0.1 
year from 1997 to 2009 and 0.3 years from 1991 to 2006 was observed in the 
Netherlands and Denmark, respectively (72, 105). In the Danish study, however, the 
significance did not hold after adjusting for differences in BMI. They, like us, could 
not find large differences in the BMI between the two studies (72). However, the 
Dutch study found, similar to us, that the difference in occurrence of menarche 
remained significant, also when adjusting for BMI SDS.  
Until 1985 (from 1920) data on growth, development and menarche in Oslo 
schoolgirls were systematically recorded and processed (65, 186). No Norwegian 
studies have compared ages at menarche in a similar way after this. Therefore, a 
comparison with previously published ages at menarche had to be based on various 
studies in Paper III. The comparison we were able to perform in Paper II was therefore 
particularly interesting since it was the first to study the age at menarche in 
comparable cohorts in almost 35 years in Norway (65). Although the decline was more 
pronounced when all girls from both studies (the BGS1 and the BGS2) were 
compared, the decline of 2.8 months was still significant when limited to Norwegian 
girls and adjusted for the BMI SDS in Paper II. It is also noteworthy that the BMI in 
the BGS2 was slightly lower compared to that in the BGS1, which suggest that the 
change is not explained by increased overweight. 
Is there a renewed trend towards earlier maturation among Norwegian girls? 
Our estimated age of 12.7 years seems to be lower than the age reported in most 
studies conducted within Norway in recent years. The North-European countries have 
shown a limited age range from 12.8–13.13 years during the last two decades (15, 30, 
67, 72, 105). A recently published population-based study including 312,656 
Norwegian women born between 1936 and 1964, recalled ages at menarche that 
ranged from 13.18–13.42 years with a u-shaped pattern between the oldest and 
youngest women suggesting that the age at menarche fluctuated within a limited range, 
but had not declined (66). When reviewing the published ages at menarche in Norway, 
our estimate for girls with a known Norwegian origin (mean age: 13.1 years) was still 
in the lower range compared to previous estimates (Figure 5). However, larger 
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population-based studies following similar designs and conducted in different 
geographical areas within Norway should be carried out to explore how the trend of 
pubertal timing develops in Norway.  
 
Figure 5 An overview based on Norwegian studies including estimates on 
age at menarche for children, adolescents or women born from 1840–2005 
(58, 65, 66, 78, 187-194). Open markers are retrospective surveys in adult 
women. Filled markers are studies with schoolchildren. *Arithmetic mean of 
reported age at menarche according to Lien et al. (188), and mean age at 
menarche calculated with probit regression from the prevalence by year of 
age (marked with an arrow). 
 
Since the observed change in our study did not appear to be attributable to 
changes in BMI, further studies should also investigate the potential role of EDCs on 
pubertal timing in Norway. Interestingly, the ages at menarche were positively skewed 
in the BGS2 but not in the BGS1. EDCs have frequently been implicated when trying 
to find explanations for changes in pubertal timing. Parent et al. recently suggested 
that changes in the age distribution for both earlier (Tanner B2) and later (menarche) 
markers may be due to the influence of EDCs (97). 
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5.2.6 Tempo of maturation versus adiposity  
In Paper III, we speculated that if menarche is triggered or associated with an increase 
in fat mass, menarche would be more strongly associated with skinfolds and waist 
circumferences because these are more direct measures of fat tissues, while BMI also 
measures lean mass and fat mass. However, the risk of an earlier age at menarche 
among girls with an elevated BMI SDS could not be explained by increased measures 
of WC, SSF or TSF in our study. Thus, our results were not suggestive of a stronger 
association between central fat or subcutaneous fat mass and the timing of menarche 
than for the BMI SDS and the timing of menarche. Although the timing of menarche 
was related to all weight-related anthropometric measurements, the age at menarche 
had remained stable before the BGS1, despite an overall increase in overweight and 
obesity. Therefore, we believe that the strong association between timing of menarche 
and these measurements to be related to the tempo of maturation more than adiposity. 
The maturational effect on BMI was also recently shown by Sorensen and Juul 
(195), by estimating adiposity with BMI and body fat percent (from bioelectrical 
impedance analyses). They found that adiposity was not significantly increased in 
early maturing girls compared to normal and late maturing girls within the same 
pubertal stage, although the BMI SDS were higher among the early maturers (195).   
Interestingly, low levels of SSF and not TSF tissue remained significantly 
associated with a later timing of menarche in the fully adjusted model. Low adiposity 
has been related to later pubertal timing and is regularly seen in girls with anorexia 
nervosa or frequent and/or intense physical activity (196). However, the 
aforementioned Danish study warned that the BMI SDS may underestimate adiposity 
in pubertal children with late maturation (195). Our finding that a low level of BMI 
SDS was significantly associated with a late timing of menarche also when adjusting 
for the level of SSF SDS suggests that there is an association between truncal 
subcutaneous thinness and later maturation. Interestingly, the more ‘peripheral’ 
measure of subcutaneous tissue, TSF, lacked significance.   
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6. Conclusions 
The following conclusions are drawn in accordance with the specific aims and 
hypothesis of the thesis: 
 Ultrasound can reliably be used to assess pubertal breast development on a 
scale from 0 to 5 in healthy girls. The ability of the ultrasound method to 
determine if girls had signs of pubertal breast maturation or not, was very good 
both within and between observers. 
 
 Direct measurements of the size and volume of glandular breast tissue lacked 
the necessary precision to be of use in clinical practice. 
 
 The stage of breast development according to ultrasound was in overall good 
agreement and often in accordance with the Tanner B staging. Contrary to what 
we hypothesised, the onset of breast development was detected earlier when 
assessed with ultrasound compared to the Tanner B method. 
 
 Pubertal development started earlier than what the current pubertal references 
imply, and this finding was expected with regards to the current trends in 
pubertal timing that have been observed in other Western countries. Norwegian 
girls do not seem to enter puberty significantly earlier than their peers in 
neighbouring countries. 
 
 A decline in the age at menarche between the BGS1 and the BGS2 was 
observed. The decline was significant, also when adjusting for body mass index 
and ethnic background. This finding warrants further investigation in 
population-based studies to monitor ongoing changes in pubertal timing and to 
find potential causes for this trend. 
 
 Measures of BMI, subcutaneous fat (skinfolds) and central fat (WC) were all 
associated with earlier and later timing of menarche. In a fully adjusted analysis 
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of all the measurements together, only a high BMI was related to earlier 
menarche, and a low BMI and a low SSF were associated with later menarche. 
This outcome was not what we hypothesised, and we concluded that the 
association between BMI and the timing of menarche may reflect the degree of 
maturation more than the adiposity. 
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7. Future perspectives 
Ultrasound has emerged as a feasible method to determine the breast developmental 
stage. It may be used as an additional assessment when in doubt about whether breast 
development has started in a girl after a clinical examination. In case of longitudinal 
follow-up of girls to monitor their pubertal progression, ultrasound facilitates a 
retrospective analysis of previous ultrasound images and a comparison with the current 
appearance. For these applications, an ultrasound-based staging system and references 
will help guide radiologists or paediatric endocrinologists in interpreting the findings. 
Another advantage of ultrasound is that it is readily available. However, the method 
may be perceived as technically more challenging to perform than Tanner B staging, 
and practice is required for proficiency. Our findings apply to healthy girls and need to 
be replicated in other populations, such as in girls with overweight and obesity. 
The study suggests that ultrasound is more sensitive to the early changes in 
breast tissue before pubertal onset. However, longitudinal studies of breast 
development from before pubertal onset will also be needed to clarify how these 
different appearances relate to the pubertal onset and if all girls experience all stages. 
Such studies would also have the potential to shed light on the discrepancies between 
ultrasound staging and Tanner B staging around the time of pubertal onset. 
This research also has clinical implications for the evaluation of puberty in 
paediatric and adolescent female patients in Norway by providing the first Norwegian 
pubertal references. Very few studies have included the assessments of pubertal 
development other than menarche in Norway, and our results provide a necessary 
scientific base that can be used for comparison in future studies. Our study support the 
finding that the pubertal timing (including menarche) may still be changing. Changes 
in growth and maturation may reflect conditions that also affect the health and 
development of the overall society, and should be of interest and concern for health 
policy makers. Routine measurements of school-aged children are recommended in 
Norway. The third and last one takes place at the age of 13–14 years. No assessments 
on pubertal maturation are included in these measurements; however, asking the girls 
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if they have experienced menarche may be an easy way to monitor the pubertal timing, 
although this is a late sign. 
It is important to identify possible causes and determinants of pubertal timing, and 
early puberty in particular, because many diseases and conditions have been linked to 
the timing of puberty. The decline in age at menarche did not seem to be explained by 
overweight. Another contributor to the trend may be EDCs, an issue that will soon be 
explored in blood samples collected in the BGS2. Further, most children (including 
approximately 500 girls) who participated in the BGS2 agreed that we could use their 
previously registered data on growth in infancy and childhood (0–6 years), so that we 
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Context: Discriminating adipose and glandular tissue is challenging when clinically assessing 
breast development. Ultrasound facilitates staging of pubertal breast maturation (US B), but has 
not been systematically compared to Tanner breast (Tanner B) staging, and no normative data 
have been reported.
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B reast development in girls is usually defined clinic-ally by the 5-stage scale as described by Marshall 
and Tanner in 1969 (1,2). The Tanner breast (Tanner B) 
scale ranges from B1 (prepubertal) to B5 (mature), in 
which stage B2 marks the first appearance of glandular 
breast tissue (thelarche) and thus the start of central pu-
berty. Clinical breast staging relies on visual inspection 
and palpation to distinguish the glandular breast tissue 
from adipose tissue, but this approach is often perceived 
as challenging. With ultrasound (US), we, and others, 
have been able to identify distinctive breast develop-
mental stages based on changes in the appearance and 
relative amount of glandular, adipose and fibrous tissues 
(3–5). Despite being a promising method, US staging of 
the breast has not yet been systematically compared 
with clinical Tanner B staging in a large developmen-
tally diverse sample, and no normative references have 
yet been published.
In Norway and other northern European countries, 
only marginal changes in age at menarche have been 
reported during the last decades (6–10). However, data 
from Denmark and the United States have shown that 
the onset of breast development might be advancing 
toward younger ages (7,11,12). A  worldwide secular 
trend toward younger ages at thelarche according to 
race/ethnicity and geography was also shown in a re-
cent systematic review (13). Accordingly, these studies 
suggest an asymmetrical secular trend of earlier breast 
development, while age at menarche remains more 
stable. Early puberty, and early menarche in particular, 
have been associated with increased all-cause mortality 
(14), a higher risk of breast cancer (15), cardiovascular 
disease (16), and mental health problems (17). It has 
been suggested that this secular trend may be caused by 
overweight or endocrine disrupting chemicals (18,19).
The present study is a part of the Bergen Growth 
Study 2 (BGS 2), which is the first large-scale pubertal 
reference study conducted in Norway. In addition to data 
on menarche and traditional Tanner B and pubic hair 
(PH) stages, we collected data on breast developmental 
stage assessed with US (US B) as a novel methodological 
approach. The aim of the current work was to provide 
descriptive reference ranges for these phenotypic traits in 
a large sample of contemporary girls living in Norway, 
to compare both methods of staging breast development, 
and to assess recent changes in age at menarche.
Materials and Methods
Study design and participants
A total of 1349 girls between 6 and 16 years of age from 
6 randomly selected public schools in Bergen municipality, 
Norway, were invited to participate. Bergen is the second lar-
gest city in Norway and the demographic profile and living 
conditions are very similar to those in the country at large 
(20). Parental consent was received prior to examination from 
678 girls (50.3%) from January to June 2016. The partici-
pation rates varied with age, from 52.1% before 12 years to 
43.4% above 13  years, and between schools, from 29.1% 
to 59.4%. In addition, data on breast development from 57 
girls examined in February 2017 for a reliability study were 
included in the analysis. Details from this study have been 
published previously (5). A  parental questionnaire with in-
formation on chronic illness, parental origin, socioeconomic 
status, and menarche was obtained from 482 (68.6%) girls. 
Five girls were absent on the day of examination, and 27 
girls were excluded due to a disease likely to affect growth or 
maturation, leaving 703 girls eligible for the analysis. Of 466 
girls with known origin of both parents, 374 (80.2%) were 
Norwegian, 408 (88.9%) European, and 51 girls (11.1%) had 
1 or 2 non-European parents, mostly from Asia (n = 30), Africa 
(n = 12), or South America (n = 7) (Supplementary Table 1, all 
supplementary materials and figures are located in a digital 
data repository (21)). The analyses are based on all girls, re-
gardless of their origin. The highest educational level of both 
parents was used as an indicator of socioeconomic status. This 
level was classified as primary education (9 years of school), 
secondary education (12 years of school), or higher education 
(college degree). Demographics of the study populations from 
Bergen Growth Study 1 (BGS 1) and BGS 2 are summarized in 
Supplementary Table 1 (21).
The median (range) age in the final sample was 10.7 
(6.1–16.2) years. Due to missing data (menarche was not re-
corded in 3 girls, 3 girls declined examination of the breast, and 
81 declined examination of PH, and the US image could not be 
retrieved for off-site scoring in 4 girls), the pubertal references 
are based on 696 observations of US B, 700 of Tanner B, and 
643 of menarche. Data on the Tanner PH stage were available 
for 372 girls as further explained in the following discussion.
Examinations
The girls were examined during school hours. All examin-
ations were performed by a single female nurse (ISB), who was 
trained in US staging of breast development by an experienced 
pediatric radiologist (KR) before and at the start of the ac-
tual data collection. Pubertal development was assessed with 
the girl in the supine position. The US examinations were per-
formed using a Sonosite Edge machine (Fujifilm SonoSite, US) 
with a 15–6 MHz (5 cm) linear probe. Based on a standard 
mid-sagittal section, breast development was scored on a scale 
from 0 to 5, consistent with our previously published descrip-
tions (5). US breast staging was conducted based on radio-
logic characteristics (Supplementary Figure 1, (21)). In brief, a 
small, hypoechoic retro-areolar mass is scored as US B0, while 
a hyperechoic area (with or without a small hypoechoic mass) 
is US B1. Both US B0 and US B1 are considered prepubertal. 
US B2 is characterized by the presence of hyperechoic retro-
areolar glandular breast tissue with a round or star-shaped 
hypoechoic center. This stage is assumed to mark the start of 
puberty (3,5). US B3 is characterized by a larger, spider-shaped 
hypoechoic center, becoming increasingly roundish in US B4 
(5). The mature US B5 is characterized by heterogeneous glan-
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US B2 to B4. The left breast was examined according to the 
protocol. Due to logistic reasons, the US stage was determined 
at a later time in 166 girls, by the same examiner, based on 
the standardized US images. This was done to avoid the girls 
becoming uncomfortable due to prolonged exposure. Based 
on a reassessment of 120 saved images, we determined that 
this had little impact on the results. Intra- and inter-observer 
agreement of US B staging was determined in an additional 
study of 57 girls (5). Cohen’s kappa was estimated at 0.84 and 
0.71, respectively, which is commonly considered good to very 
good agreement (22).
The development of the breasts and PH was clinically 
scored on a scale from 1 to 5 (B1–B5 and PH1–PH5) ac-
cording to the method described by Tanner (1), which is based 
on a visual inspection, although palpation of the breast was 
included in this procedure. Pubertal onset is defined as Tanner 
B2, which is characterized by the visual and/or palpable ap-
pearance of glandular tissue. The left breast was always exam-
ined, however, in 3 cases the right breast was found more 
advanced according to Tanner B staging and therefore used in 
the references (Tanner B staging recorded additionally on the 
right side in 453 girls). A subsample of 453 girls were asked 
if the examiner could assess the Tanner PH by visual inspec-
tion, to which 372 (82.1%) assented. Because of assumed time 
constrains, Tanner B staging of the right breast and Tanner 
PH staging were not included in the protocol at the start of 
the study but were only added and systematically recorded 
from February 22 until the end of the data collection. Tanner 
PH2 marks the first appearance of PH (1,2). All participants 
were asked if they had experienced their first menstruation 
(menarche) and the month/year, if applicable. Missing data on 
menarche were completed with data from the parental ques-
tionnaire for 16 girls. Two girls above 15 years of age were 
encouraged to see their general practitioner due to primary 
amenorrhea.
Height was measured in the standing position with a 
Harpenden Portable Stadiometer (Holtain Ltd Crosswell, UK) 
and recorded to the nearest 0.1 cm. Weight was measured in 
light clothing with an electronic scale (Tanita MC-780MA, 
Tanita Corp. of America, Inc. Illinois, US) with a precision of 
0.1  kg. Body mass index (BMI) was calculated by dividing 
weight (in kg) by the square of height (in meters). The BMI 
was available for 645 (91.7%) girls of whom 14.6% were 
overweight (including obesity) and 7.3% were underweight 
according to the definitions from the International Obesity 
Task Force (23,24).
Statistical analysis
Age at menarche or entry into a certain puberty stage 
was estimated from age and pubertal status of the girls with 
a generalized linear model (probit regression) and with a 
nonparametric generalized additive model (GAM) for binary 
outcomes with probit link. The methods differ by the assump-
tion of a normal age distribution (probit) or not (GAM). The 
probit and GAM curves were estimated for each consecutive 
stage separately. The degree of smoothing of the GAM was 
determined by generalized cross-validation and models were 
checked with diagnostic plots using the mgcv package (25) 
in R version 3.5 (R Foundation for Statistical Computing, 
Vienna, Austria, 2018). Primarily, the median, percentiles, and 
equivalent z-scores of age at entry from the nonparametric 
additive model are reported in the tables. In addition, we re-
port the mean and standard deviation (SD) from the para-
metric probit models to allow a comparison with data from 
other studies. In addition to reference data based on all eli-
gible girls, we estimated age at menarche and transition to 
US B2, Tanner B2, and Tanner PH2 in the subgroup of girls 
with a documented Norwegian or non-Norwegian origin. The 
statistical significance of differences between Norwegian and 
non-Norwegian girls was tested with logistic regression using 
age as a covariate and origin (Norwegian, non-Norwegian) as 
the variable of interest. This analysis was limited to girls with 
a documented origin only.
Agreement between US B and Tanner B staging was ana-
lyzed with simple Cohen’s kappa and Cohen’s kappa test with 
linear weights. The kappa statistic gives a coefficient between 
0 (no agreement) and 1 (perfect agreement) (22). For these 
comparisons, the US B0 and B1 stages were collapsed into a 
single prepubertal stage. Separate analysis of agreement and 
percentage concordance between the methods were done for 
girls with normal weight and overweight (including obesity).
To investigate if age at menarche had advanced in the 
Bergen municipality since the first Bergen Growth Study 
(BGS 1), conducted in 2003 to 2006, we compared girls with 
a documented Norwegian or Nordic (1.5%) background 
in both studies to avoid interference from demographic 
changes in the population. Details from BGS 1 have been 
published elsewhere (10). In brief, girls from 8 to 15.5 years 
(n  =  1481) were asked if they had experienced their me-
narche, and this was the only pubertal marker recorded in 
BGS 1. The occurrence of menarche was compared between 
both studies with logistic regression using age, BMI z-score, 
and parental educational level as covariates. Logistic re-
gression, and agreement analyses were done in Statistical 
Package for Social Sciences (SPSS version 24) and R (ver-
sion 3.5).
Ethical considerations
The project was approved by the Regional Committee for 
Medical and Health Research Ethics West Norway (number 
2015/128/REK Vest). Written informed consent was obtained 
from a parent or legal guardian of each participant and also 
from the participants 12 years and older. All girls received age-
appropriate information in writing and orally by the study 
nurse ahead of participation. Assent from the participant was 
an additional requirement for inclusion. All participants re-
ceived a cinema ticket for their collaboration.
Results
The medians and equivalent z-scores, means, and SD 
for age at entry into consecutive US B, Tanner B and 
PH stages, and menarche are presented in Table  1. 
Traditional age percentiles of all pubertal markers are 
provided in Supplemental Table 2 (21). Reference quan-
tiles were calculated nonparametrically from the cu-
mulative distribution estimated with a GAM, which in 
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The distribution of age at onset of breast develop-
ment measured with US was slightly ahead of the Tanner 
method. However, the opposite was true for the higher 
maturational stages, where the age at transition with the 
Tanner method was ahead of the assessment with US. 
The mean age (SD) of thelarche was 10.2 (1.3) years 
with US (US B2), and 10.4 (1.2) years with the Tanner 
method (Tanner B2). The lower end of the normal range 
defined by a z-score of –2 SD was 7.7 and 8.0 years, 
respectively, while the corresponding upper limits were 
12.8 and 12.7 years.
The breast developmental stage assessed with US 
and the Tanner method was concordant in 551 of 695 
(79.3%) girls for whom both assessments were avail-
able (kappa  =  0.87; 95% confidence interval [CI]; 
0.85–0.89) (Table  2). When dichotomizing the breast 
developmental stage into thelarche or not thelarche, 
the agreement was very good (kappa = 0.94; 95% CI; 
0.91–0.96). US identified breast development (US B 
≥2) in 18 girls in whom the mammary gland was not 
palpable (corresponding to Tanner B1). Opposite, three 
girls had clinical signs of pubertal breast development 
(Tanner ≥B2) with no glandular breast tissue visible on 
US (US B0 or US B1). The kappa coefficients when com-
paring the 2 methods were 0.88 (95% CI 0.86–0.91) 
and 0.85 (95% CI: 0.79–0.90) for girls with normal 
and overweight/obesity, respectively. Full concordance 
between US B and Tanner B staging was found in 81.6% 
and 73.4% of girls with normal weight and overweight/
obesity, respectively.
Pubic hair development (Tanner ≥PH2) was ob-
served in 182 of 372 (48.9%) girls. The mean (SD) age 
at Tanner PH2 was estimated as 10.9 (1.2) years. The 
age distribution of each Tanner PH stage was close to 
normal (Fig. 1C).
In total, 193 of 643 (30.0%) girls had experienced 
menarche. The median (±2 SD) age at menarche was 
12.7 (11.0–16.2) years. This is 2.5 years after thelarche 
according to the US method (US B2) and 2.3 years after 
thelarche according to the Tanner method (B2). A com-
parison of the probit model and the GAM indicated a 
positive skewness in the distribution of age at menarche 
(Fig. 1D).
The onset of all pubertal markers occurred earlier 
in girls with a non-Norwegian origin (n  =  92) com-
pared to girls with two parents of Norwegian origin 
(n  =  374), in the subset of girls with known origin 
(74%) (Supplemental Table 3 (21)). The difference was 
only statistically significant for the start of breast de-
velopment according to US (P  <  .05). Compared to 
girls from BGS 1, mean (SD) age at menarche in girls of 
Norwegian, including Nordic, origin had significantly 
declined from 13.3 (1.7) years (not previously pub-
lished) in 2006 to 13.1 (1.2) years in 2016 (P < 0.05). 
Table 1. Age References for Breast Development, Pubic Hair and Menarche: Median and Distribution (–2, 
–1, 1, 2 SD) of the Age (in Years) at Attainment of the Specified Stage
Generalized Additive Model   
Age at Attainment Probit
Pubertal marker –2 SD –1 SD Median 1 SD 2 SD Mean (SD) age
Breast (ultrasound)       
 US B1 NA 5.6a 8.3 10.7 12.4 8.3 (2.2)
 S B2 7.7 8.9 10.2 11.5 12.8 10.2 (1.3)
 US B3 9.1 10.3 11.5 12.7 13.9 11.5 (1.2)
 US B4 10.4 11.3 12.3 13.9 NA 12.7 (1.5)
 US B5 11.3 12.7 15.9 NA NA 15.3 (2.3)
Breast (Tanner)       
 B2 8.0 9.2 10.4 11.6 12.7 10.4 (1.2)
 B3 9.5 10.4 11.4 12.5 13.8 11.5 (1.1)
 B4 10.7 11.6 12.5 13.8 NA 12.8 (1.3)
 B5 11.1 12.3 14.7 NA NA 14.8 (2.2)
Pubic Hair (Tanner)   
 PH2 8.5 9.7 10.9 12.1 13.3 10.9 (1.2)
 PH3 9.7 10.9 11.9 12.9 13.7 11.9 (1.1)
 PH4 10.5 11.8 13.1 14.4 15.7 13.1 (1.3)
 PH5 11.4 13.0 15.1 NA NA 15.1 (1.9)
Menarche 11.0 11.7 12.7 14.1 16.2 12.9 (1.2)
Distribution of age at entry in consecutive stages of breast development measured with ultrasound (US B; n = 696), breast development according to 
Tanner B (n = 700), Pubic hair (PH) according to Tanner (n = 372) and menarche (n = 643) in 6- to 16-year-old healthy girls in Bergen, Norway. Me-
dian age and ±1 or 2 reference limits were estimated with nonparametric generalized additive models. Mean (SD) ages were estimated with probit 
regression. 
Abbreviations: B, breast; NA, not applicable (outside the data range); PH, pubic hair; SD, standard deviation; US B, ultrasound-based breast stage.
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Figure 1. Age reference curves. Age distribution of pubertal development in 6- to 16-year-old girls living in Norway. A: Stages of breast 
development with ultrasound (n = 696); B: Breast development stage by Tanner stage (n = 700); C: Pubic hair (PH) according to Tanner (n = 372); 
D: Menarche (n = 643). Black lines show the parametric probit model, assuming a Gaussian distribution of the age at transition; grey lines show 
the corresponding curves of the nonparametric generalized additive model with a probit link; connected dots show the cumulative proportion of 
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The difference in occurrence of menarche between both 
studies remained statistically significant (odds ratio 2.0; 
95% CI 1.1–3.6; P  =  .016), when accounting for the 
BMI z-score and parental educational level. Parental 
education was not retained in the final models because it 
was not significantly associated with menarche in either 
study. The age distribution in both studies is shown in 
Supplementary Figure 2 (21) for all girls in the study and 
in Supplementary Figure 3 (21) for girls of Norwegian/
Nordic origin.
Discussion
In this study, we describe female pubertal develop-
ment using a large contemporary sample of healthy 
girls living in Norway. The results are summarized as 
age percentiles, which can serve as normative reference 
intervals for pubertal milestones in the Norwegian and 
other comparable populations. Up-to-date references 
are important to support clinical decision-making. In 
addition to the traditional Tanner stages, we have also 
documented breast development based on US examin-
ation of glandular breast tissue. Our results show a high 
degree of concordance between the 2 methods, but the 
start of breast development is detected almost 2 months 
earlier with US staging. Finally, our results indicate that 
there might be an ongoing decrease in the age at me-
narche in the Norwegian population.
The principle of assessing breast development with 
US examination of the mammary gland has been pro-
posed by several authors (4,5,26–28), but US staging 
of breast development was not yet compared with clin-
ical staging in a large sample of healthy pubescent girls, 
and no reference data were available. The 4 studies that 
could be identified were small (<80 subjects) or based 
on a heterogeneous clinical sample (4,26–28). US sta-
ging is a promising technique with a good intra- and 
inter-observer reliability (5) that may overcome several 
known limitations of the visual and palpatory method 
described by Tanner. In the present study, we have 
shown that both methods agree well with each other 
in a large sample of girls at various stages of their de-
velopment, also when stratifying by weight category. 
The kappa statistic showed good agreement over all five 
stages and very good agreement when girls were clas-
sified as having thelarche or not. The biggest discrep-
ancy was observed between Tanner B5 and US staging, 
but in most cases, this difference was 1 stage only. This 
may be due to the statistical model because only about 
half of the girls have reached stage 5 by the end of the 
age range of girls included in the study (differences are 
smaller at –1 or –2 SD) but could also reflect a discrep-
ancy between the size of the breast and maturation of 
the gland as visualized with US or reflect an overlap of 
the characteristics of stages 4 and 5 with the Tanner and 
US methods.
However, the latter comparison also indicated that the 
US method is probably more sensitive to pick up changes 
that are consistent with the start of pubertal breast de-
velopment. In addition, US examination identifies two 
distinct developmental stages (denoted as US B0 and US 
B1) in girls who are prepubertal (B1) according to the 
Tanner method. This has not been acknowledged in pre-
vious studies by other authors (5). Both these stages are 
considered by us as prepubertal and future research will 
indicate to what extent they correlate with physiological 
and hormonal changes. For the comparison of the US and 
Tanner methods both prepubertal stages were merged.
The mean age at thelarche according to the Tanner 
method (B2) was 10.4 years with an SD of 1.2 years. While 
no historical data are available for the Norwegian popula-
tion, other studies reported a substantial decline in onset of 
breast development (Tanner B2) from 10.9 years in 1993 to 
9.9 years in 2008 in Danish girls living in the Copenhagen 
area (7). However, a more recent population-based longi-
tudinal study of self-reported onset of breast development 
found a mean age at thelarche of 10.4  years, which is 
more comparable to our findings (29). A declining age at 
Table 2. Distribution of Breast Development with Ultrasound and Tanner Staging
Breast Development With Ultrasound
Tanner stage US B0 US B1 US B2 US B3 US B4 US B5 Total
B1 166 129 18 0 0 0 313
B2 1 2 63 12 2 0 80
B3 0 0 13 43 25 2 83
B4 0 0 0 15 77 16 108
B5 0 0 0 5 33 73 111
Total 167 131 94 75 137 91 695
Agreement of the breast developmental stage according to Tanner (B1 to B5) and ultrasound examination (US B0 to B5) in 695 6- to 16-year-old 
girls in Bergen, Norway. US B0 and US B1 and Tanner B1 are prepubertal stages; stages US B0 and US B1 are merged for the analysis of method 
agreement.
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thelarche has also been reported in the United States (11,30) 
and in the United Kingdom (9), but studies from Belgium (6) 
and the Netherlands(31) reported a mean age at thelarche 
of 10.7 years, without an apparent trend toward younger 
ages. The lower reference limit (–2 SD) for age at attaining 
Tanner B2 was 8.0 years in the current study. Overall, these 
findings suggest that the onset of breast development in 
Norwegian girls is neither earlier nor later when compared 
to other northern European countries and that the current 
age limit of precocious puberty in girls (ie, start of breast de-
velopment before 8 years) can be maintained, as is the case 
in other countries (6,32). Likewise, we reported a mean (SD) 
age of the start of PH development (Tanner PH2) of 10.9 
(1.2) years, which corresponds well with the mean ages of 
11.0 to 11.1 years reported in northern European popula-
tions (6,7,31).
Mean age at menarche fluctuates within a narrow 
range from 12.9 to 13.1  years in most studies from 
northern Europe (6,7,9,29,33). Although age at me-
narche has been remarkably stable for more than half 
a century, a small but statistically significant decline has 
been reported in Denmark and the Netherlands (0.3 and 
0.1 years, respectively) (7,33). A recent study from the 
United States reported an overall median age at menarche 
of 12.3 years and in white girls 12.7 years (12), which is 
only a modest change from a previous U.S. study where 
the age at menarche in white girls was 12.9 years (11). 
In the current study, we found a median age at menarche 
of 12.7 years, which is in line with the white girls from 
the United States, but earlier than the cited northern 
European studies. However, we previously reported an 
overall median age at menarche of 13.1 years in BGS 1 
from 2006 (10). The age at menarche in Norway has 
been stable just above 13 years during the last 50 years 
(10,34). To rule out possible interference from recent 
changes in the composition of the target population 
such as origin, BMI, and socioeconomic background, 
we compared a subsample of girls with a documented 
Norwegian origin from both studies and included BMI 
and parental educational level in the analysis. Parental 
education was not significantly associated with age at 
menarche, but there was a significant effect of the BMI 
as was documented before (10). The statistically signifi-
cant decrease with 2.8 months in age at menarche since 
2006 was however not affected by the inclusion of the 
BMI z-score in the models because the BMI distribution 
was highly comparable in both studies. An increased ex-
posure to endocrine disruptive chemicals remains a pos-
sible hypothesis, to which we cannot offer a conclusive 
answer in the current analysis (19). Given the potential 
importance of this finding, we believe it should be con-
firmed in a larger population-based study.
For the descriptive reference ranges of menarche and 
secondary sexual characteristics we have included all girls 
regardless their origin in the reference sample because their 
impact on the reference limits is relatively small from a 
clinical perspective, and implementation of a single ref-
erence might be more feasible. Establishing and adapting 
reference curves to fit an increasingly demographically 
heterogenic composition where growth and puberty 
timing of the native population is different to that of im-
migrant populations remain an epidemiological challenge.
Although the BGS 2 included a large number of chil-
dren at or near puberty and covers many aspects of pu-
bertal development, some limitations should be noted. 
The schools were randomly selected and cover various 
socioeconomic conditions, but they were all situated in 
mostly urban areas of the municipality of Bergen. The 
prevalence of overweight (including obesity) of 14.6% 
in our study is slightly lower than, but still comparable 
to, data from the first Bergen growth study (17.7%) (35) 
and to data from a nationally representative sample of 
9-year-old girls (17%) (36). Including girls from different 
Norwegian regions would have increased generalizability 
but would also have introduced logistic challenges and 
could have negatively impacted the standardization of 
measurement procedures. The recruitment strategy is 
also a potential source of selection bias, that is, when 
girls with a relatively early or late puberty are more re-
luctant to participate. Our study sample is representative 
of the Norwegian population with respect to origin (37). 
Girls of non-Norwegian origin were included in the ana-
lysis since this reflects the natural variation in the target 
population. Although this increases the applicability of 
the references in the Norwegian population at large, it 
may also hamper the comparability of the data with 
other nations or future studies. For this reason, we also 
provided references based on a subsample of girls with a 
Norwegian background as supplementary material (21). 
Our knowledge about the nonparticipants is limited to 
school and grade. However, there was a slightly lesser 
participation rate in schools with a larger number of 
children with a non-Norwegian background. Increased 
nonparticipation in these schools may have been caused 
by language barriers or cultural preferences of parents.
One of the potential advantages of US staging of breast 
development relates to difficulties with Tanner staging in 
girls with obesity. We observed that the agreement and con-
cordance between the two breast staging methods were 
slightly lower among the girls with overweight and obesity 
and that the clinical assessment, Tanner B, showed a more 
mature stage compared to the US B in more cases among 
the girls with overweight than in the normal weight group 
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B2 would have been preferable to further examine the rela-
tion between US B and Tanner B around the clinical stage 
that defines pubertal onset. Another limitation is the low 
response, even though we consider the participation rate 
of 50% as relatively high for this particular type of study. 
Information on health and ethnicity were only known when 
the questionnaire was answered and returned by parents 
(69%), which may have resulted in the inclusion of some 
girls with relevant pathology unknown to us. However, the 
prevalence of such conditions was low in girls with a ques-
tionnaire available, and including or excluding them had 
little impact on the resulting estimates (data not shown).
In conclusion, we found that US and Tanner B sta-
ging are in close agreement when determining the de-
gree of pubertal breast maturation. US allows for a 
direct examination of the mammary gland and detects 
pubertal breast development slightly ahead of clinical 
Tanner B staging. Moreover, this method allows to dis-
criminate 2 distinct prepubertal stages, the clinical rele-
vance of which will be the subject of further research. 
Pubertal breast and PH development in Norwegian girls 
occur at comparable ages as in their northern European 
peers. In girls of Norwegian origin, age at menarche 
occurred at a significantly younger age than 10 years 
before. This trend toward earlier menarche merits fur-
ther investigation.
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Supplementary Table 1 Comparison of the Bergen Growth Studies 1 and 2 
Demographic characteristics of the study samples in the Bergen Growth studies 1 and 2. 




Study characteristics Bergen Growth Study 1  Bergen Growth Study 2 
Year of study 2003-2006 
 
2016 
Study setting randomly selection of 20 schools 
and 34 kindergardens  
(all children 0-19 years of age) 
 
6 randomly selected schools 
(all pupils 6-16 years invited) 
Included in comparison of 
occurrence of menarche 
1485 (8 to 15.5 years)  643 
Age, mean (SD) 11.8 (2.2)  11.1 (2.8) 
BMI, mean (SD)  18.5 (2.9)  18.3 (3.2) 
BMI z-score, mean (SD) -0.01 (1.0)  0.04 (1.0) 
Exclusion chronic illness (n=39) 
 
chronic illness (n=27) 
Participation rate 69% in primary schools (6-12 
years) 
53% in middle schools (13-14 
years) 
 52.1% in primary schools(6-12 years) 
43.3% in middle schools (13-16 
years) 
Ethnic composition (%) Norwegian/Nordic: 1294 (87.1%) 
European: 67 (4.2%) 
Non-European: 120 (8.1%) 
 
 
Girls with known origin: 466 
Norwegian/Nordic origin: 381 (81.2 
%) 
European origin: 27 (5.8 %) 
Non-European: 51 (11.1%) 
Parental education 
(highest degree) 
   
  No secondary education 71 (7.6%)  16 (3.3%) 
  Secondary education 280 (29.9%)  82 (17.1%) 
  Higher education  583 (62.4%)  382 (79.6%) 
    
Weight status (IOTF)    
  Underweight 144 (9.7%)  47 (7.2%) 
  Normal 1128 (75.9%)  504 (78.1%) 
  Overweight 180 (12.1%)  80 (12.4%) 
  Obese 33 (2.2%)  14 (2.2%) 
2 
 
Supplemental Table 2. Age percentiles of ultrasound (US B) and Tanner (B) based stages of 
breast development, Tanner stages of pubic hair (PH) and menarche (M) in healthy 6 – 16 
years old girls in Norway. The median (P50) and percentiles 3 to 97 of age at entry were 
derived from nonparametric generalized additive models (GAM) with a probit link function. 
 
Pubertal marker P3 P10 P25 P50 P75 P90 P97 
Breast (Ultrasound; n=969) 
US B1 NA NA 6.5 8.4 10.0 11.2 12.2 
US B2 7.8 8.6 9.4 10.2 11.1 11.9 12.6 
US B3 9.2 10.0 10.7 11.5 12.3 13.0 13.7 
US B4 10.5 11.0 11.6 12.3 13.3 14.7 NA 
US B5 11.5 12.2 13.3 15.9 NA NA NA 
        
Breast (Tanner; n=700)  
Tanner B2 8.2 8.9 9.6 10.4 11.2 11.9 12.6 
Tanner B3 9.7 10.2 10.8 11.4 12.1 12.9 13.7 
Tanner B4 10.8 11.3 11.9 12.5 13.3 14.3 16.4 
Tanner B5 11.2 11.9 12.9 14.7 NA NA NA 
        
Pubic Hair (Tanner; n=372) 
Tanner PH2 8.6 9.3 10.1 10.9 11.7 12.4 13.1 
Tanner PH3 9.8 10.63 11.3 11.9 12.6 13.1 13.6 
Tanner PH4 10.6 11.4 12.2 13.1 13.8 14.8 15.5 
Tanner PH5 11.6 12.6 13.6 15.1 NA NA NA 
        
Menarche (n = 643) 
 11.0 11.5 12.0 12.7 13.5 14.5 15.9 
Abbreviations: SD: standard deviation; US B: ultrasound-based breast stage Tanner B: Tanner 







Supplemental Table 3. Estimated mean ages at reaching ultrasound-based breast stage 2 (US 
B2), Tanner breast stage 2 (B2), Tanner pubic hair stage 2 (PH2) and menarche, in the girls 
with known non-Norwegian (n = 92) and in girls that are known to be of Norwegian origin (n 
= 374). 
 Non Norwegian Norwegian origin  
Puberty measure n Mean SD 95% CI n Mean SD 95%CI P-value 
US B2 92 9.84   1.16 (9.37 - 10.3) 371 10.46 1.29 (10.21 - 10.71) 0.04 
Tanner B2 92 10.13   1.00 (9.70 - 10.56) 372 10.56 1.24 (10.32 - 10.80) 0.10 
Tanner PH2 59 10.44   1.11 (9.86 - 11.01) 205 11.08 1.16 (10.75 - 11.40) 0.08 
Menarche 92 12.64   1.33 (12.01 - 13.27) 374 13.08 1.19 (12.79 - 13.37) 0.10 
Abbreviations: SD: standard deviation; CI: confidence interval; P-value from logistic regression using age as a 
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Figures and figure legends to Supplemental Figures 1, 2 and 3 
 
 
Supplemental Figure 1. Ultrasound-based stages of pubertal breast development (US B) 
A Midsagittal view through the left breast in a 7.1-year-old girl conforming to stage US B0. 
Image shows a small elongated mass (asterisk) hypoechoic relative to the surrounding 
subcutaneous (SC) adipose tissue. The ribs (R) are located posterior to the pectoral muscle (P) 
(1). 
B Midsagittal view through the left breast in a 10.8 –year-old girl conforming to stage US B1. 
The breast tissue is hyperechoic compared to the surrounding subcutaneous tissue (SC), but 
not to the pectoral muscle (P) and has a triangular shape (asterisk) (1). 
C Midsagittal view through the left breast in a 9.7-year-old girl conforming to stage US B2. 
The image shows well-defined breast tissue that appears hyperechoic in relation to the 
subcutaneous (SC) tissue, but not to the pectoral muscle (P), and has a small hypoechoic 
roundish centre (asterisk). Rib (R) (1). 
D Midsagittal view through the left breast in a 10.7 –year-old girl conforming to stage US B3. 
The breast tissue appears hyperechoic with a hypoechoic “spider-shaped” centre (asterisk). 
Pectoral muscle (P) (1). 
E  Midsagittal view through the left breast in a 12.0 –old-girl conforming to stage US B4. The 
image shows hypoechoic glandular tissue in the subareolar area that has a rounder shape 
compared to US B3. The ribs (R) are located posterior to the pectoral muscle (P) (1). 
F Midsagittal view through the left breast in a 13.9-old-girl conforming to stage US B5. 
Mature breast tissue is seen as a heterogeneous mass without any hypoechoic centre. Pectoral 




Supplemental Figure 2  
Cumulative proportion of girls with menarche by age estimated with a generalized additive 
model for binary data with probit link. Data from all girls included in the studies from 2006 
(BGS1) and 2016 (current study, BGS2). Grey areas indicate the standard errors below/above 




Supplemental Figure 3 
Cumulative proportion of girls with menarche by age estimated with a generalized additive 
model for binary data with probit link. Data from girls of Norwegian or Nordic origin in the 
studies from 2006 (BGS1) and 2016 (current study, BGS2). Grey areas indicate the standard 
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Timing of menarche in Norwegian girls:
associations with body mass index, waist
circumference and skinfold thickness
Heiko Bratke1, Ingvild Særvold Bruserud2, Bente Brannsether3,4, Jörg Aßmus5, Robert Bjerknes3,
Mathieu Roelants6 and Pétur B. Júlíusson2,3*
Abstract
Background: Research studies show conflicting results regarding the association between menarche and body
weight. The purpose of the present study was to investigate if anthropometric indicators of body composition,
body mass index (BMI), waist circumference (WC), triceps (TSF) and subscapular skinfold (SSF) thicknesses, were
differentially associated with age at menarche in Norwegian girls.
Methods: The association between menarche and BMI, WC, TSF and SSF was investigated in 1481 girls aged 8–15.
5 years, and in a subgroup of 181 girls with menarche during the 12 months prior to examination. Anthropometric
measures were categorized as low (< −1SDS), average (−1 ≤ SDS ≤ +1) or high (> 1SDS), and menarche according
to this classification was analysed with Kaplan-Meier curves and unadjusted and adjusted Cox regression.
Results: The median age at menarche in the total sample was 13.1 years. In the unadjusted models, low categories
of all traits were associated with later menarche, and high categories with earlier menarche. When adjusted for
other covariates, earlier menarche was only related with a high BMI (Hazard Ratio 1.41, 95% confidence interval (CI)
1.07, 1.85), and later menarche with a low BMI (HR 0.53, 95%CI 0.38, 0.75) and low SSF (HR 0.54, 95%CI 0.39, 0.75). In
girls with recent menarche, early menarche was significantly associated with a high BMI in the final model (HR 1.79,
95%CI 1.23, 2.62).
Conclusions: The timing of menarche was associated with the BMI, WC, TSF and SSF, but more strongly so with
the BMI. These associations may be related to a common tempo of growth, as the mean age at menarche has
remained stable during the last decades during a time period while the prevalence of overweight and obesity has
increased significantly.
Keywords: Menarche age, Puberty, Overweight, BMI, Skinfold thickness, Waist circumference
Background
In Western populations, the age at menarche has de-
clined about 0.3 years per decade until the 1950’s [1, 2].
In Norwegian girls, the mean age at menarche was re-
ported to be above 16 years in 1830, whereas it has been
stable around 13 years since the 1940s [3–6]. In con-
trast, studies from Denmark and the US showed a fur-
ther decline in the age of pubertal onset in girls, in
particular the age of breast development [7, 8]. Changes
in age at menarche were however modest, suggesting
asymmetrical secular trends in the timing of pubertal de-
velopment [7, 9].
The observed variation in the activation of the
hypothalamic-pituitary-gonadal axis and menarche, re-
flects interactions between genetic background and vari-
ous endogenous and exogenous factors [1]. Prenatal
conditions, nutrition and body composition, light expos-
ure, endocrine disrupting chemicals (EDC) and psycho-
social stress have been suggested as possible regulators
of this development [1, 10].
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In the early 1970s, Frisch and Revelle suggested a “crit-
ical weight” theory, pointing out the relationship be-
tween weight and pubertal timing [11]. Later, the leptin
hormone secreted by fat tissue, has been shown to func-
tion as a signal for energy status and as a permissive fac-
tor for pubertal onset by modulating the Kiss1/Kiss1R
system [12]. The Kiss1/Kiss1R system seems to represent
a link between the reproductive and the energy system,
influenced not only by leptin, but also ghrelin, insulin,
pro-opiomelanocortin and neuropeptide Y [13]. There-
fore, one can speculate that the increase in the preva-
lence of overweight and obesity should result in a
downward trend in pubertal timing, and several studies
have provided evidence for this association [14, 15].
However, a Danish study showed that, although a rela-
tively high BMI was consistently associated with an earl-
ier onset of the pubertal growth spurt in children born
between 1930 and 1969, such a trend was also seen in
girls with a low BMI. Therefore, the BMI alone could
not explain the observed downward trend [16].
In the present study, age at menarche was compared
to anthropometric indicators of body composition in
Norwegian girls, notably body mass index (BMI), waist
circumference (WC), and triceps (TSF)- and subscapular
(SSF) skinfold thickness. Our hypothesis was that mea-
sures of subcutaneous and/or central fat tissue would
correlate more strongly with age at menarche compared
to an overall index of body weight.
Methods
The present analysis is based on a sample of 8–15.5 year
old girls who participated in the Bergen Growth Study
(BGS). This cross-sectional study on growth from birth
to 19 years of age included 4035 girls measured in
2003–2006 and representative for Bergen County. All
participating girls in the included primary schools
(grades 1–10) were visually assessed by a study nurse for
signs of breast development, and subsequently asked
about menarche and, if applicable, age at menarche
(month/year) [17]. From this study population, 68 girls
were excluded because of diseases known to affect
growth, and 4 because of incomplete information. In
total, 1481 girls were between 8 and 15.5 years and thus
eligible for inclusion in the present study (“total study
sample”). Girls who had their menarche during the
12 months preceding the measurement represented a
subgroup of “girls with recent menarche”. Age at menar-
che was recorded and height, weight, WC, TSF and SSF
were measured according to standardized procedures
[17–19]. Briefly, height was measured to the nearest
0.1 cm with a portable Holtain stadiometer (Crosswell,
UK) and weight to nearest 0.1 kg with a Seca personal
digital scale (Hamburg, Germany). Waist circumference
was measured at the end of normal expiration with a
Lufkin W606 PM metal measurement tape placed at the
midpoint between the lowest rib and the top of the iliac
crest. Skinfolds were measured on the left side with a Hol-
tain Skinfold Caliper (Crosswell, UK). The TSF was mea-
sured on the back side of the upper arm midway between
the acromion and the radial head. The SSF was measured
2 cm below the inferior angle of the scapula. The rationale
for choosing these were threefold: [1] the triceps and sub-
scapulae are common sites for taking skinfolds; [2] at
these sites, the measurements are easier to perform and
standardize compared to other measurement sites; and [3]
we wanted to include both a “peripheral” (TSF) and more
central or “truncal” (SSF) site. All anthropometric mea-
sures were converted to SD scores (SDS) using national
growth references, and categorized as low (< −1SDS),
average (−1 ≤ SDS ≤ +1) or high (> 1SDS).
Statistical analysis
Median age at menarche was estimated with Kaplan-
Meier analysis, taking into account that girls who had
not yet reached menarche are right censored. The mean
and variance were estimated with probit analysis of sta-
tus presens data assuming a Gaussian distribution of age
at menarche in the total sample, and calculated as the
arithmetic mean and SD in the subgroup with recent
menarche. The association between the menarche and
the anthropometric measures (BMI, WC, SSF and TSF)
was analysed with Cox proportional hazards models.
Predictor variables were grouped as low, average or high
as described above, and the average group was used as
the reference category. In addition, BMI was also classi-
fied as an ordinal variable with four levels according to
IOTF (International Obesity Task Force) criteria for
overweight (the equivalent of a BMI ≥ 25 kg/m2 in
adults) and obesity (equivalent of BMI ≥ 30 kg/m2), and
the analogous criteria for underweight (the equivalent of
a BMI ≤ 18.5 kg/m2) [20, 21]. The IOTF-classification
was included because its common use in clinical and re-
search settings. Results are presented for unadjusted
simple regression models of each marker separately, fully
adjusted multiple regression models including all an-
thropometric measures, and final models which are the
result of a (backwards) stepwise removal of statistically
not significant covariates (using p > 0.1 as a conservative
criterion for removal). The sample size of the Bergen
Growth Study was estimated with the aim to detect
secular changes in height and weight since the 1970s. A
post hoc power analysis of the present study shows that
the sample allows to detect a statistically significant haz-
ard ratio of approximately 1.3 in the analysis of all girls,
and a hazard ratio of approximately 1.5 in the subgroup
of girls with recent menarche.
Test results with a p-value less than 0.05 were consid-
ered as statistically significant. Data analysis was done
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using IBM SPSS release 21.0 and in R version 3.2 (R
Foundation for Statistical Computing, Vienna, Austria,
2015).
Results
Of the total study sample of 1481 girls, 477 reported me-
narche, of whom 181 had experienced their first men-
struation during the 12 months preceding measurement
(“girls with recent menarche”). In the total study sample,
the Kaplan-Meier median age at menarche was 13.1 years
(95%CI 13.0–13.3), while the probit mean was 13.3 years
(95%CI 13.1–13.4) with a corresponding SD of 0.9 years.
In girls with recent menarche, the median age at menar-
che was 13.2 years (95%CI 13.0–13.4), and the probit
mean 13.2 (95%CI 13.0–13.3) with a corresponding SD
of 0.9 years.
In the total study sample, the IOTF-defined prevalence
of overweight including obesity was 14.4%, and that of
underweight 9.7%, and in girls with recent menarche,
11.1% and 13.8%, respectively.
In the unadjusted analysis of the total study sample,
low BMI SDS was associated with later menarche and a
high BMI SDS with earlier menarche (Table 1, Fig. 1).
Comparable results were obtained for WC, TSF and SSF.
In the fully adjusted model, a high BMI was significantly
associated with menarche at an earlier age, and both a
low BMI and low SSF with menarche at a later age.
Backward elimination of non-significant variables pre-
served the level of significance and did not alter the cor-
responding Hazard ratios by more than 0.04. The timing
of menarche was associated with the IOTF weight clas-
ses in a similar way: median age (95%CI) was 12.5
(12.1–13.0) years in girls with overweight including
obesity (n = 213), 13.1 (13.0–13.2) years in girls with
normal weight (n = 1124), and 14.1 (13.7–14.6) years in
girls with underweight (n = 144).
The same trends were observed in the group of girls
with recent menarche, but with a lower significance
level, probably because of the smaller sample size (Table
1). Also, the effect sizes were usually larger for the high
categories of BMI, WC, TSF and SSF, and smaller for the
low categories, when compared to the total cohort.
Discussion
In the present study, we found a median age at menar-
che in Norwegian girls of 13.1 years. Although the tim-
ing of menarche was strongly related to all weight
related anthropometric variables, early menarche was
only significantly associated with a high BMI, and late
menarche with a low SSF or low BMI in multiple Cox
regression analysis.
The mean age of menarche in Norwegian girls has
been stable for more than half a century, while the
prevalence of overweight and obesity has continued to
rise during the past decades [22, 23]. Rosenberg et al. re-
ported the age at menarche between 1830 and 1960
using recall data from Norwegian maternity hospitals,
and showed a steady decline that reached a nadir just
above 13 years of age in the 1940s [3]. More recently,
comparable estimates of age at menarche in Norwegian
girls have been published by Tell et al. [5], using youth
data from Oslo, and by Bratberg et al., using data col-
lected from 1995 to 2001 for the Young-HUNT study
[6]. The estimates from our own study conclude this list
and confirm that age at menarche in Norwegian girls
has not changed since the 1940s. The current median
age at menarche of 13.1 years in Norwegian girls is simi-
lar to that observed in other North-European countries
[1]. Recent findings from the USA, Denmark and the
Netherlands showed a slight decrease in menarcheal age
during the last decade [7, 9, 24]. We could not docu-
ment such a trend, in Norwegian girls.
All weight-related anthropometric variables were
strongly associated with the timing of menarche. A rela-
tively low value of the BMI, WC, TSF and SSF was asso-
ciated with menarche at a later age, and a relatively high
value with an earlier age at menarche. Earlier studies
have linked early menarche to higher weight status in
childhood [25, 26], and Adair et al. found a higher
prevalence of overweight in girls with menarche before
11 years compared to those with a menarche after
14 years of age [27]. This difference remains up to young
adulthood at least, as follow-up of young women with
early menarche showed higher BMI and larger skinfold-
thickness at the age of 21 and 27 years, when compared
to women with late menarche [28]. Finally, using data
from 34 European countries and North America, Currie
et al. could show that at on an individual level, age at
menarche was 1 month earlier for each unit increase in
BMI [14]. Further, mean age at menarche was approxi-
mately 1 week earlier with each percentage point in-
crease in prevalence of overweight/obesity at country
level [14]. About 14.4% of the girls in our study were
overweight according to the IOTF. Although this esti-
mate roughly corresponds to a threefold increase in the
prevalence of overweight during the past decades [22], it
is surprising that the age at menarche has not changed
during this period. This indicates that the mechanism
behind the association between weight status and tempo
of maturation, at least for menarche as an endpoint, may
be more complex than a direct causal relation.
In the multiple Cox regression model, a relatively high
BMI was related with early menarche and low BMI or
SSF was with late menarche. Our hypothesis was that
measures of subcutaneous fat tissue like TSF and SSF,
would show a stronger relation with menarche than the
BMI, which measures both fat mass and lean mass.
However, the present findings show the opposite, as we
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found the BMI to be a consistent predictor of early and
late menarche. This suggests a strong association be-
tween the increase in BMI and tempo of maturation,
and could explain why menarche is more closely related
to the BMI than to measures of subcutaneous (skinfolds)
or central (WC) fat tissue. However, the later menarche
in girls with a low SSF is equally interesting as one can
speculate that SSF, as a measure of truncal subcutaneous
fat tissue, has more impact on maturational processes
than TSF, which is a measure of peripheral fat tissue.
A limitation in the present work is that girls might
have changed weight status between menarche and the
Table 1 Kaplan-Meier estimates and Cox regression of menarche according to the BMI, WC, TSF and SSFa in the total sample and in
girls with recent menarche
Unadjusted modelb Fully adjusted modelb Final modelb
N Median HR (95% CI) P HR (95% CI) P HR (95% CI) P
All girls (N = 1481)
BMI
Low 262 14.1 0.40 (0.30–0.55) <0.001 0.56 (0.39–0.82) 0.001 0.53 (0.38–0.75) <0.01
Normal 960 13.1 1.00 1.00 1.00
High 259 12.6 1.46 (1.16–1.84) 0.001 1.45 (1.03–2.05) 0.01 1.41 (1.07–1.85) 0.01
WC
Low 236 13.7 0.54 (0.40–0.71) <0.001 0.93 (0.67–1.30)
Normal 1000 13.1 1.00 1.00
High 244 12.8 1.33 (1.04–1.71) 0.01 0.86 (0.59–1.24)
TSF
Low 235 13.6 0.59 (0.45–0.78) <0.001 0.97 (0.72–1.30)
Normal 988 13.1 1.00 1.00
High 248 12.7 1.33 (1.04–1.71) 0.01 1.01 (0.73–1.41)
SSF
Low 237 14 0.40 (0.29–0.54) <0.001 0.53 (0.37–0.75) <0.001 0.54 (0.39–0.75) <0.01
Normal 965 13.1 1.00 1.00 1.00
High 273 12.8 1.21 (0.95–1.54) 1.03 (0.73–1.45) 0.96 (0.72–1.27)
Girls with recent menarche (N = 181)
BMI
Low 26 13.60 0.76 (0.50–1.17) 0.92 (0.51–1.66) 0.76 (0.50–1.17)
Normal 118 13.10 1.00 1.00 1.00
High 37 12.70 1.79 (1.23–2.62) 0.001 1.19 (0.67–2.12) 1.79 (1.23–2.62) 0.003
WC
Low 19 13.70 0.82 (0.50–1.33) <0.001 0.99 (0.52–1.87)
Normal 131 13.20 1.00 1.00
High 31 12.60 1.96 (1.32–2.94) 0.01 1.40 (0.79–2.48)
TSF
Low 36 13.50 0.80 (0.55–1.17) 1.08 (0.69–1.70)
Normal 119 13.10 1.00 1.00
High 23 12.70 1.74 (1.11–2.74) 1.11 (0.61–2.04)
SSF
Low 25 13.50 0.65 (0.42–1.00) 0.050 0.66 (0.39–1.14)
Normal 124 13.10 1.00 1.00
High 32 12.70 1.71 (1.15–2.53) 0.01 1.25 (0.73–2.13)
aGrouped as low (< −1 SDS), normal (> −1 SDS – > +1 SDS) or high (> +1 SDS) BMI, WC, TSF and SSF. Estimates and models based on the total sample take into
account that some girls have not yet reached menarche (censored)
b Unadjusted models are simple Cox regression models for each marker separately; fully adjusted models are multiple Cox regression models including all
anthropometric markers; and final models are multiple Cox regression models after backward elimination of statistically not significant covariates (p > 0.1)
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time of examination, in particular during puberty. Be-
cause of this possibility, we repeated our analysis in a
subsample of girls who had their menarche within
12 months (mean time since menarche was 6.3 months)
prior to the date of measurement [29]. The analysis of
this subgroup showed the same trends as in the total
study group, although not always statistically significant,
probably due to the loss of statistical power because of
the much smaller sample size. A further limitation is the
cross-sectional nature of the data. Because of this, no
causal conclusions can be made.
Conclusion
Although timing of menarche was clearly associated with
weight-related anthropometric measures in Norwegian
girls, the increasing prevalence of overweight and obesity
seems to have had little impact on the mean age at me-
narche. Therefore, the observed association between
weight-related anthropometric measures and menarche
might be reflecting maturation to a larger extent than
the degree of adiposity. This is also supported by the
findings in the current study that anthropometric mea-
sures of subcutaneous fat tissue (TSF, SSF) and central
fat (WC) did not show stronger relationship to menar-
che than BMI.
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Forespørsel om deltakelse i forskningsprosjektet 
Barn under 12 år 





I 2003-6 gjennomførte vi «Vekststudien i Bergen 1» som gjorde det mulig å tegne vekstkurver som er 
brukt i hele landet. Med dette brevet ber vi om deres samtykke til å inkludere deres barn i en studie 
for å utforske pubertetsutviklingen til norske barn. Vi vet svært lite om denne utviklingen, noe som er 
problematisk når en skal vurdere om et barn har for tidlig eller har for sen utvikling (da trenger vi 
informasjon om hva som er normalt). I andre land, for eksempel Danmark og USA, har en de siste 
årene funnet tegn på at pubertetsutviklingen kommer tidligere nå enn før. Det er uklart hva dette 
skyldes. Det er mulig at barn går tidligere i pubertet pga endret kroppssammensetning (økt fettvev) 
eller stoffer i omgivelsene (såkalte hormonhermere) som kan påvirke utviklingen. Tidlig 
pubertetsutvikling kan være uheldig og øke risikoen for overvekt og høyt kolesterol senere i livet. I 
tillegg har noen studier vist assosiasjon mellom for tidlig pubertet og enkelte kreftformer. Hensikten 
med studien er å kartlegge normal pubertetsutvikling hos norske barn ved å vurdere vekst og utvikling, 
måling av hormoner i blod og spytt og kartlegge de genene som er involvert. I tillegg ønsker vi å 
undersøke faktorer som kan påvirke utviklingen med måling av kroppssammensetning og forekomsten 
av hormonhermere i kroppen. 
 
Hva innebærer studien? 
Studien innebærer målinger av høyde, vekt og mageomfang. Alle undersøkelsene vil skje på skolen til 
barnet. En kvinnelig sykepleier vil måle størrelsen av brystkjertlene med ultralyd hos jentene og en 
mannlig radiograf vil måle størrelsen av testiklene hos guttene, også med ultralyd, og utvikling av 
kjønnshår registreres. En blir godt dekket til og barna skal ikke føle seg eksponert. Vanligvis vil en ikke 
trenge å ta av seg undertøy/singlet. En og en blir undersøkt om gangen og adskilt fra andre. I tillegg 
blir kroppssammensetningen målt med bioimpetanse, et utstyr som måler hvor mye muskler, knokler 
og fett det er i kroppen. I etterkant av dette blir det tatt blodprøve og spyttprøve. Alle undersøkelsene 
tar kort tid og er smertefrie (unntatt blodprøvestikk, men hvis barnet ditt ønsker det, kan en få 
bedøvelsessprey på huden først). Vi ber deg/dere også om å fyllet ut et spørreskjema. 
 
Mulige fordeler og ulemper 
Hvis en oppdager avvikende høyde, vekt eller pubertetsutvikling hos ditt barn vil vi informere om 
dette. Barnet vil få en skriftlig tilbakemelding hvor sin nåværende høyde er oppgitt. Ellers vil en ikke ha 
noen spesiell fordel av deltakelse, men barnet er med på å lage en «normal» for pubertetsutviklingen i 
Norge. Slik informasjon vil hjelpe andre barn som har avvikende utvikling fordi det er lettere å 
identifisere dem når en vet hvordan normal pubertetsutvikling er. Studien vil også gi verdifull 
informasjon om faktorer som påvirker pubertetsutviklingen. Ulempe med studien vil være litt ubehag i 
forbindelse med blodprøvetaking. 
 
Hva skjer med prøvene og informasjonen om barnet?  
Vi vil oppbevare prøver og informasjon om barnet slik at det kan brukes i pågående og fremtidige 
forskningsprosjekter for å finne mekanismer som ligger bak pubertetsutviklingen. Prøvene og 
informasjonen som registreres vil bli behandlet konfidensielt og vil bare bli brukt til forskning innen 
pubertetsutvikling. 
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Det er kun autorisert personell knyttet til prosjektet som har adgang til navnelisten og som kan finne 
tilbake til barnet. Det vil ikke være mulig å identifisere barnet i resultatene av studien når disse 
publiseres. 
 
For noen forskningsprosjekter kan det være aktuelt å sammenstille data fra våre studier om pubertet 
med offentlige registre, som for eksempel Reseptregisteret, Medisinsk fødselsregister, Kreftregisteret, 
Dødsårsaksregisteret og andre registre som er basert på opplysninger fra sykehus og 
primærhelsetjeneste. Alle slike sammenstillinger krever godkjenning av de offentlige instanser som er 
fastsatt i norsk lov. 
 
Du/dere kan få jevnlig oppdatert informasjon om forskningsprosjekter som er omfattet av dette 
samtykket på www.vekststudien.no. 
 
Frivillig deltakelse 
Det er frivillig å delta i studien. Dere kan når som helst og uten å oppgi noen grunn trekke samtykket til 
å delta i studien. Dette vil ikke få konsekvenser. Dersom dere ønsker å delta, undertegner dere 
samtykkeerklæringen på siste side. Om dere nå sier ja til å delta, kan dere senere trekke tilbake deres 
samtykke. Dersom dere senere ønsker å trekke dere eller har spørsmål til studien, kan du/dere 
kontakte postdoktor/overlege Pétur B. Júlíusson (mobil tlf. 97777079 eller epost 
petur.juliusson@helse-bergen.no). 
 
Alle som deltar i studien vil få en kinobillett og et diplom med informasjon om høyden sin! 
 
Ytterligere informasjon om studien finnes i kapittel A – utdypende forklaring av hva studien 
innebærer. 
Ytterligere informasjon om biobank, personvern og forsikring finnes i kapittel B – Personvern, 
biobank, økonomi og forsikring. 
 








Pétur B. Júlíusson 
Overlege/Postdoktor 
Barneklinikken 
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Kapittel A- utdypende forklaring av hva studien innebærer 
 
 Alle barn på skolen blir invitert til å delta. 
 I Norge har vi ingen informasjon om normal pubertetsutvikling hor norske barn. I Danmark og 
USA har en observert utvikling mot tidligere pubertet de senere år. Det er ukjent hva som 
forårsaker dette. I vår studie ønsker vi å få informasjon om normal pubertet hos barn i Norge 
og å finne faktorer som kan påvirke utviklingen. 
 Vi vil måle barnets høyde og vekt samt mageomfang, og også bruke ultralyd til å måle 
utviklingen av bryst og testikler. Hos jentene blir «lydhode» satt på brystet mens området 
rundt blir godt dekket til. Hos guttene blir en slik «lydhode» lagt på en testikkel, mens 
området rundt er godt dekket til. Utviklingen av kjønnshår registreres. Barnet skal ikke på noe 
tidspunkt oppleve at det blir eksponert. Vanligvis vil en ikke trenge å ta av seg 
undertøy/singlet. Kun ett og ett barn blir målt om gangen. I etterkant blir 
kroppssammensetningen målt med såkalt bioimpetanse (utstyr som måler hvor mye muskel, 
skjelett og fett er i kroppen din) og avslutningsvis blir det tatt blodprøve og spyttprøve. En 
undergruppe blir bedt om å levere inn urinprøve. 
 Dere foreldre/foresatte blir bedt om å fylle ut et spørreskjema. 
 Undersøkelsen vil foregå på skolen, og ett og ett barn blir undersøkt adskilt fra hverandre. Det 
hele vil ta ca 15 minutter. 
 Undersøkelsen skal ikke gi noe ubehag utenom blodprøvetaking. Hvis ønskelig kan barnet få 
bedøvelsessprey på huden før det tas blodprøve. 
 Studiens ansatte vil gi grundig informasjon om forskningsprosjektet i klasserommet. Barna tar 
med seg hjem dette informasjonsskrivet/samtykkeerklæringen/spørreskjema. Kun de barna 
som leverer tilbake undertegnet samtykke blir undersøkt. 
 
 
Kapittel B - Personvern, biobank, økonomi og forsikring 
 
Personvern 
Så snart opplysningene og prøvene er samlet inn vil de bli lagret uten navn og fødselsnummer eller 
andre direkte gjenkjennende opplysninger. En kode knytter barnets opplysninger og prøver gjennom 
en navneliste. Det er kun autorisert personell knyttet til prosjektet som har adgang til navnelisten og 
som kan finne tilbake til barnet. Alle medarbeidere i prosjektene har taushetsplikt. Dere kan føle dere 
trygg på at informasjonen om barnet og prøvene vil bli behandlet med respekt for personvern og 
privatliv, og i samsvar med lover og forskrifter. Det vil ikke være mulig å identifisere barnet i 
resultatene av studien når disse publiseres. Data som inngår i studien barnet deltar i vil anonymiseres 
ved studienes slutt. 
 
Biobank 
Blod- og spyttprøvene som blir tatt vil bli lagret i en forskningsbiobank ved Haukeland 
Universitetssykehus. Hvis du/dere sier ja til å delta i studien gir du/dere også samtykke til at det 
biologiske materialet og analyseresultater inngår i biobanken. Pétur B. Júlíusson er ansvarshavende 
for forskningsbiobanken. Det biologiske materialet kan bare brukes etter godkjenning fra Regional 
komité for medisinsk og helsefaglig forskningsetikk (REK). Hvis det i fremtiden blir aktuelt å bruke 
prøver eller opplysninger om barnet til noe annet enn pubertetsstudier, kan det bli nødvendig å be 
om et nytt samtykke. Vi vil da sende dere et brev. Du/dere kan også bli spurt om et nytt samtykke 
hvis det blir aktuelt å samarbeide med private aktører om genetisk forskning. Slikt samarbeid vil være 
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underlagt offentlig regulering og kontroll. Det vil ikke i noen tilfeller være aktuelt å selge blodprøver 
eller annet biologisk materiale. 
 
Biobanken vil inneholde følgende: 
De opplysningene som inngår er barnets navn og fødselsnummer samt prøvematerialet. I Biobanken 
lagres nedfryst biologisk materiale fra barna som følges ved Barneklinikken ved Helse Bergen HF.  
Prøvene vil analyseres i forbindelse med spesifiserte forskningsprosjekter. 
 
Hvem kan få tilgang til prøvematerialet? 
Prøvene lagres permanent. Alle analysene foregår på avidentifisert materiale, men det kan bli aktuelt 
å koble materialet med opplysninger fra f.eks. registrere (om diagnose, behandling o.s.v.) og da 
brukes fødselsnummeret for å sammenstille prøve med opplysninger fra registeret. Når dette er gjort 
avidentifiseres prøver og datafiler. Alle som arbeider med analysene har taushetsplikt om forhold de 
får kjennskap til gjennom dette arbeidet. 
 
Innsynsrett, endring og sletting av opplysninger 
Du/dere kan til enhver tid få innsyn i hvilke opplysninger/prøver som er registrert om barnet. 
Du/dere har videre rett til å få korrigert eventuelle feil i de opplysningene vi har registrert. I tillegg 
kan du/dere når som helst kreve at innsamlede prøver og opplysninger om barnet blir 
slettet/destruert, uten at du må oppgi noen grunn. Sletting av data og biobankmateriale vil ikke 
innebære sletting fra anonymiserte forskningsfiler som allerede er benyttet i forskning.  Det vil ikke 
ha noe betydning for barnet dersom du/dere velger å ikke avgi prøve, eller dersom du/dere senere 
ønsker å trekke deg. 
 
Utlevering av materiale og opplysninger til andre 
Utlevering av prøvemateriale vil bare skje til forskere i form av avidentifiserte prøver. Det vil si at alle 
prøver vil bli behandlet uten navn og fødselsnummer eller andre direkte gjenkjennende opplysninger. 
En kode knytter barnet til barnets prøver gjennom en navneliste. Det er kun autorisert personell 
knyttet til biobanken som har adgang til navnelisten og kan finne tilbake til barnet. Det kan bli aktuelt 
å sende prøver til analyser i utlandet, fortrinnsvis land i EU/EØS, men også andre land kan være 
aktuelle, f.eks. USA. Navnelisten vil uansett forbli i Norge. Skulle dette bli aktuelt vil nærmere 
opplysninger vil bli lagt ut på biobankens hjemmesider. 
 
For forskningsprosjekter kan det være aktuelt å sammenstille informasjon fra biobanken med 
opplysninger fra sykejournal, helseundersøkelser, helseregistre og andre offentlige administrative 
registre. Alle forskningsprosjekter må imidlertid forhåndsgodkjennes av Den regionale komité for 
medisinsk forskningsetikk og andre offentlige instanser som loven krever. 
 
Du kan følge med på aktuelle forskningsprosjekter på vår internettside: www.vekststudien.no 
Registeransvarlig/kontaktperson: Overlege/postdoktor Pétur B. Júlíusson, Barneklinikken, Haukeland 
Universitetssykehus. Tlf: 55975200. 
 
Rett til innsyn og sletting av opplysninger om deg og sletting av prøver 
Hvis du/dere sier ja til å delta i studien, har dere rett til å få innsyn i hvilke opplysninger som er 
registrert om barnet. Dere har videre rett til å få korrigert eventuelle feil i de opplysningene vi har 
registrert. Dersom barnet trekker seg fra studien, kan du/dere kreve å få slettet innsamlede prøver 
og opplysninger, med mindre opplysningene allerede er inngått i analyser eller brukt i vitenskapelige 
publikasjoner. 
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Samtykke til deltakelse i studien og biobanken 
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